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The eukaryotic parasite Leishmania is the causative agent of the disease 
leishmaniasis.  L. major is the most common of 21 species that causes visceral 
leishmaniasis in humans, and 30 that cause the same disease in other mammals.  Visceral 
leishmaniasis causes fever, weight loss, and over a short amount of time, multiple organ 
failure, and has a 100% mortality rate within 2 years.  This makes it the second largest 
parasitic killer in the world behind malaria. Over 90% of the world’s cases of visceral 
leishmaniasis have been reported in underdeveloped countries of India, Bangladesh, 
Nepal, Sudan, Ethiopia and Brazil, with 500,000 new cases being diagnosed worldwide 
each year.  Nonetheless, the most popular drugs of choice for leishmaniasis treatment 
remain toxic, expensive, or subject to refractory infections.   
Phospholipids used to construct biological membranes account for approximately 
70% of total cellular lipid in Leishmania, and of that 30-40% is phosphatidylcholine 
(PC).  PC is formed via the Kennedy pathways in Leishmania, as well as in many higher
eukaryotes, including mammals.  The enzyme CTP: phosphocholine cytidylyltransferase 
(CCT) catalyzes the addition of cytidine triphosphate (CTP) to phosphocholine yielding 
CDP-choline, a second, critical, rate limiting step in the formation of PC by the Kennedy 
pathway that has been shown to be reversibly membrane associated.  Amino acid 
sequence analysis of CCT shows a high level of homology in the CCT catalytic region 
but a lack of the known carboxy terminal membrane-binding region in L. infantum and L. 
major.  Thus, the nuclear localization signal, along with the classical carboxy terminal 
membrane binding domain is absent in these organisms and it is unknown whether CCT 
localizes to the nucleus, endoplasmic reticulum, or cytoplasm.  
In investigation of the enzyme, the gene for L. major CCT has been tagged with a 
red fluorescent protein gene (mCherry) and successfully cloned into non-pathogenic 
Leishmania tarentolae.  Confocal microscopy has revealed that L. major CCT is 
primarily cytoplasmic, while most likely also able to reversibly associate with internal 
membranes such as the endoplasmic reticulum and plasma membrane.  CTP: 
phosphoethanolamine cytidylyltransferase (ECT), an analogous enzyme of 
phosphatidylethanolamine (PE) synthesis, was also shown to be exclusively cytosolic 
using the same technique.  In addition, a truncated mutant of L. major CCT containing 
the catalytic domain has been expressed in Escherichia coli and purified.  In vitro assay 
of the enzyme yielded a maximal velocity (Vmax) of approximately 374 nmol/min/mg and 
substrate constant (Km) values of 0.0648 mM and 3.74 mM respectively for the substrates 
CTP and phosphocholine.  The Mg2+ ion was used as a cofactor in the reaction, but the 
enzyme was also able to achieve maximal activity using Mn2+, Co2+, Ni2+, and possibly 
Fe 2+.  Additionally, the enzyme was most active at 37oC and pH 7.5.  This summarizes 
investigation of CCT as a possible therapeutic target for more efficacious treatment of 
leishmaniasis. 
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CHAPTER I 
BACKGROUND AND INTRODUCTION 
Infection by Leishmania and Treatment of Leishmaniasis 
Leishmania is a protozoan parasite that is the causative agent of leishmaniasis, a 
disease which threatens 350 million people, mostly in third world countries.  Over 90% 
of the world’s cases of leishmaniasis have been reported in underdeveloped countries of 
India, Bangladesh, Nepal, Sudan, Ethiopia and Brazil, with 500,000 new cases being 
diagnosed worldwide each year (Figure 1; WHO, 2015).   
 
 
Figure 1. Regions Affected by Leishmaniasis.  Countries affected by leishmaniasis are 
shaded in blue.  Most are developing or undeveloped countries with tropical or sub-
tropical climates. 
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There are also different forms of leishmaniasis including cutaneous, 
mucocutaneous, and visceral, which are caused by different species of Leishmania. 
Cutaneous leishmaniasis presents with disseminated and chronic skin lesions and is most 
commonly caused by L. major, L. tropica, and L. aethiopica.  These open skin lesions 
may also become infected by opportunistic pathogens such as Staphylococcus aureus, 
which may make treatment even more difficult.  Mucocutaneous leishmaniasis causes 
lesions that can partially or totally destroy the nasal, mouth, and throat mucosa, for which 
L. braziliensis is most often the culprit.  Visceral leishmaniasis causes fever, weight loss, 
swelling of the spleen and liver, and anemia. L. donovani and L. infantum are responsible 
for this most debilitating form of the disease (Vannier-Santos et al., 2002).  Over a short 
amount of time, the disease will cause multiple organ failure, and has a 100% mortality 
rate within 2 years.  This makes it the second largest parasitic killer in the world behind 
malaria.  Of particular concern is co-infection with the human immune-deficiency virus 
(HIV), as the two diseases are mutually reinforcing.  HIV-infected people are particularly 
vulnerable to visceral leishmaniasis, while visceral leishmaniasis accelerates HIV 
replication and progression to acquired immuno-deficiency syndrome (AIDS) (WHO, 
2015; CDC, 2015). 
Leishmania is transferred between organisms by the sand flies of the genus 
Phlebotomus in the Old World (Southern Europe, North Africa, the Middle East, and 
South Asia) and Lutzomyia in the New World (Central and South America). Leishmania 
exist in two life-cycle stages: promastigote and amastigote.  Promastigotes are 
extracellular, motile, and generally 5-20 µm in length and 1-4 µm in width, with an 
anterior flagellum that usually matches the size of their cell body.  Amastigotes are 
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intracellular, nonmotile, ovular in shape, and usually 2 µm in length and 1-4 µm in width.  
Both contain a central nucleus and kinetoplast that lies anterior (Vannier-Santos et al., 
2002).  The life cycle of Leishmania starts when an infected sandfly takes a blood meal 
and injects the promastigote stage Leishmania into the host.  The promastigotes are then 
internalized by phagocytic cells, such as macrophages, where the promastigotes 
transform into amastigotes. The amastigotes then multiply and spread to other phagocytic 
cells. When a sandfly take a blood meal from this host, it will ingest the macrophages 
containing the amastigotes. These amastigotes will be converted back into promastigotes 
within the gut of the sandfly. The promastigotes then travel to the proboscis of the 
sandfly, where the cycle starts over (Figure 2; CDC, 2015).  
 
 
Figure 2. Life Cycle of Leishmania.  The parasite alters between a promastigote and 
amastigote form in both the sandfly (primary host) and mammals (secondary host). 
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Several treatment options exist for leishmaniasis, but most are given in the form 
of injection. However, treatments given intravenously are not ideal for several reasons 
including multiple hospital visits, risk of HIV co-infection, and higher costs.  Treatment 
options are also different for different species of Leishmania, different types of 
leishmaniasis, different regions of the world, and the health of the affected patient.  The 
most common and effective intravenously administered drugs for leishmaniasis include 
the pentavalent antimony derivative drug sodium antimony gluconate (SAG), the 
antifungal drug amphotericin B, and the aminoglycoside paromomycin (Singh and 
Sivakumar, 2004). The mechanism for SAG is not fully known but it is generally thought 
to inhibit glycolytic enzymes and fatty acid oxidation in amastigotes. The side effects of 
SAG and other antimony derived drugs include pancreatitis, nausea, abdominal pain, 
nerve damage, and reduction of white and red blood cells as well as platelets.  Resistance 
for this drug was first seen in the 1970s, but it still remains one of the primary drugs in 
the treatment against leishmaniasis due to its low cost (Singh and Sivakumar, 2004).  
Amphotericin B is an antifungal antibiotic that attaches to ergosterol in cell membranes, 
the major sterol in fungus and Leishmania which is not found in humans. Once attached, 
the drug prevents membrane synthesis from occurring and therefore causes the 
development of holes in the cell membrane and eventually cell death.  It has been 
discovered that this drug attaches to cholesterol in mammalian cell membranes, which 
may cause such side effects as fever, chills, bone pain, and in rare cases cardiac arrest, 
reduction of potassium levels, and kidney toxicity.  New liposomal formulations of 
amphotericin B have been made to reduce toxicity, however the cost of these new drugs 
limits them to severe cases of leishmaniasis or drug resistant strains of Leishmania only 
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(Singh and Sivakumar, 2004).  Paromomycin is an aminoglycoside antibiotic that binds 
to 16S ribosomal RNA and in turn blocks protein synthesis.  This is also often used in 
combination with antimonial compounds in treatment of severe cutaneous leishmaniasis. 
Side effects of paromomycin often include toxicity of the kidneys and vestibulocochlear 
nerve (Singh and Sivakumar, 2004).   
Several oral drugs such as pentamidine, imidazole derivatives, and miltefosine are 
also used.  Pentamidine was the first drug used in patients that had become refractory to 
pentavalent antimonials.  Its mechanism of action includes blocking replication and 
transcription in the kinetoplast mitochondria.  Accordingly, this drug causes a wide range 
of deleterious side effects, including diabetic symptoms, liver enzyme abnormalities, 
bone marrow effects like leukopenia and anemia, renal toxicity, and heart problems such 
as arrhythmia, hypotension, and heart failure (Singh and Sivakumar, 2004).  The most 
effective has been the phosphocholine analogue compound miltefosine which was 
originally developed as an antineoplastic tumor drug (Figure 3). 
 
Figure 3. Chemical Structure of Miltephosine.  Miltephosine, or 2-(hexadecoxy-oxido-
phosphoryl) oxyethyl-trimethyl-azanium, is a phosphocholine analogue. 
 
 
Much like its original purpose, miltefosine is thought to interact with protein 
kinase C in the plasma membrane of Leishmania which inhibits proliferation, alters 
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phospholipid and sterol composition, and activates cellular immunity. The drug has 
proven successful in clinical trials and is well tolerated, although low incidences of 
gastrointestinal disturbances and renal toxicity have been seen with treatment. However, 
a few species of Leishmania have showed resistance to miltefosine as early as 2003.  
Overall, the drugs available for treatment of leishmaniasis are either very costly, 
have severe side effects, or certain Leishmania species are becoming resistant towards 
them (Singh and Sivakumar, 2004).  Therefore, research is still needed in order to find 
additional pharmaceuticals and their targets for the treatment of this disease. The 
phospholipid synthesis enzyme CTP: phosphocholine cytidylyltransferase (CCT) presents 
itself as an attractive potential drug target. This enzyme is involved in the synthesis of 
phosphatidylcholine (PC), a key phospholipid found in the cell membrane of Leishmania.  
PC represents about 30-40% of total cellular lipids in Leishmania, and a decrease below 
25% has been shown to be extremely deleterious to the parasite cell (Zhang and 
Beverley, 2010).  As a result, inhibition of CCT would not only disrupt membrane 
stability and vesicular trafficking, but may also cause abnormal signaling concerning cell 
growth, reproduction, and death. 
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Membrane Composition in Leishmania, as well as Function and Synthesis of 
Phospholipids 
 Phospholipid synthesis is of extreme importance in all cells, including the 
organism of study, L. major.  Phospholipids are comprised of a polar “head group”, 
glycerophosphoric acid, and connected fatty-acyl chains.  These include 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), 
phosphatidylinositol (PI), and phosphatidic acid (PA).  The diversity of phospholipids is 
extensive, which includes having one or two fatty acyl chains, the length, branching, and 
double bond nature, or saturation, of those chains, and modification of the head group 
including phosphorylation and glycosylation.  PC in Leishmania typically exists in 1,2 
diacyl and 1-lyso-2 acyl forms consisting of unusually long and unsaturated fatty acyl 
species (Zufferey, 2003).  While not extensively studied, it is thought that the 
polyunsaturated nature of PC in Leishmania most likely influences membrane fluidity by 
reducing its melting point and contributes to resistance against host-derived oxidative 
stress (Zhang and Beverley, 2010).  
 Phospholipids are the predominant lipid component comprising cell membranes 
of eukaryotic and prokaryotic cells and, in addition to their structural role in bilayer 
formation and membrane physiology, are also important for cell signaling.  PI often 
serves as the precursor for signaling molecules found in most eukaryotic organisms 
including inositol 1,4,5-triphosphate, 1,2 diacylglycerol, arachidonic acid, 
lysophospholipids, and phosphatidic acid.  PI may also be phosphorylated at different 
hydroxyl groups on the inositol moiety to form various bioactive posphoinositides which 
regulate membrane trafficking and cytoskeleton remodeling in Leishmania (Coppolino et 
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al., 2002).  In addition, Leishmania promastigotes, as well as other protozoan parasites, 
have been known to expose a large concentration of PS on the extracellular leaflet of 
their plasma membrane upon entry into the mammalian bloodstream.  This PS exposure 
is also a sign given by apoptotic cells that phagocytic cells, such as macrophages, use to 
recognize and remove them.  It has been hypothesized that Leishmania cells mimic this 
tactic in order to gain entrance into macrophages in a “Trojan horse” like manner 
(Wanderley et al., 2006).  While signaling functions specific to PC have not yet been 
identified in Leishmania, the presence of phospholipases specific to PC that generate 
signaling molecules such as diacylglycerol, phosphatidic acid, and free fatty acids has 
been shown in other organisms.  These often regulate and are regulated by protein kinase 
C and may control intracellular levels of Ca2+ (Barnett et al., 1993).      
 In terms of concentration, two of the major phospholipids in eukaryotes are PE 
and PC, with PC often the most abundant in these cells.  However, membrane 
composition between organisms, tissues, and even individual cells often varies.  Human 
endothelial cell phospholipid composition has been studied and PC is the most abundant 
phospholipid representing 36.6% of the total phospholipids, with PE representing 10.2%, 
and PS making up another 7.1% (Murphy et al., 1992).  Yeast also contains PC in highest 
abundance with Saccharomyces cerevisiae having a phospholipid composition of 42% 
PC, 25% PE, 15% PI, 7% PS, and 9% cardiolipin (Kaneko et al., 1976).  Protozoan 
parasites such as Trypanosoma brucei, Trypanosoma cruzi, Leishmania, and 
Plasmodium, in general contain about 40-50% PC, 35-45% PE, 4-11% PI, and less than 
5% PS. Of particular interest, the membranes of L. major typically contain 33% PC, 10% 
PE, 10% PI, and 7% other phospholipids (Zhang and Beverley, 2010).  
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 There are two possible phospholipid synthesis pathways that may be employed by 
organisms: a “salvage” pathway and the Kennedy, or de novo, synthesis pathway.  In the 
salvage pathway, cytidine triphosphate (CTP) is first reacted with phosphatidic acid to 
form the product cytidine diphosphate-diacylglycerol (CDP-DAG) by CDP-DAG 
synthase.  This reaction activates the phosphodiester bond for attack by the hydroxyl 
group located on a specific head group including either choline, ethanolamine, serine, 
inositol, or glycerol, which is used by a specific synthase enzyme to yield PC, PE, PS, PI, 
or PG (Aktas et al., 2010).  The salvage pathway seems to be extensively used by 
prokaryotes and as yet no putative genes involved in this immediate pathway have been 
identified in Leishmania. 
 The Kennedy pathway differs from the salvage pathway in that CDP is first 
attached to the head group, not the DAG.  The head group is first phosphorylated and 
then acts as a nucleophile which attacks the alpha-phosphate of CTP creating a CDP-head 
group. The hydroxyl group on DAG can then act as nucleophile and attack the alpha-
phosphate of the CDP-head group to form the specific phospholipid.  The only 
phospholipids synthesized via the Kennedy pathway are PC and PE (Kennedy and Weiss, 
1956).  As previously stated, the Kennedy pathway involves three enzymatic steps in the 
formation of PC.  The first enzyme, choline kinase (CK), is soluble and phosphorylates 
choline to phosphocholine using adenosine triphosphate (ATP) as a phosphate donor, 
yielding adenosine diphosphate (ADP) as byproduct.  The second enzyme and topic of 
this study, CTP: phosphocholine cytidylyltransferase (CCT), catalyzes the addition of 
cytidine triphosphate (CTP) to phosphocholine, yielding CDP-choline and inorganic 
pyrophosphate byproduct.  CCT has been shown to be reversibly membrane associated 
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and controls the critical, rate limiting step in the formation of PC by the Kennedy 
pathway.  The third enzyme, choline phosphotransferase (CPT) catalyzes the addition of 
DAG to CDP-choline to form PC and cytosine monophosphate (CMP) as a byproduct, 
and is an integral membrane protein (Kent, 1997) (Figures 4, 5).   
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The Kennedy Synthesis Pathway for Phosphatidylcholine.  The enzyme of 
interest to this work is CCT, which catalyzes the second reaction in this pathway. 
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 Synthesis of PE is accomplished in a very similar fashion by using ethanolamine 
kinase (EK) and CTP: phosphoethanolamine cytidylyltransferase (ECT) which are 
typically cytosolic, and ethanolamine phosphotransferase (EPT) which is integrally 
membrane bound (Figure 5).  However, many organisms express dual function 
choline/ethanolamine kinases (C/EK) and/or phosphotransferases (C/EPT), while 
cytidylyltransferases are always specific (Gibellini and Smith, 2010).  The Kennedy 
pathway is used by eukaryotes and putative genes for C/EK, CCT, ECT, and C/EPT have 
been identified in Leishmania (Rogers et al., 2011).  Of greatest concern, L. major CCT 
has been experimentally characterized in this study and provides its main focus, while L. 
major ECT has been characterized by a previous member of the lab and will be examined 
to a much lesser extent (Morganthaler, 2014).  
 However, more recent research has characterized an alternative route found in 
many eukaryotes which provides metabolites for PE synthesis in Leishmania.  In this 
pathway, sphingolipids such as sphingosine-1-phosphate (S-1-P) and 
dihydrosphingosine-1-phosphate (DHS-1-P) are degraded by sphingosine-1-phosphate 
lyase (SPL) to produce phosphoethanolamine and trans-2-hexadecanal, the former of 
which is then utilized in the reaction catalyzed by ECT in de novo PE synthesis (Figure 5; 
Zhang et al., 2007).  The drastic decrease of PE content and disappearance of PC in 
double mutants lacking serine palmitoyltransferase (SPT) (spt2-), a sphingolipid synthesis 
enzyme, or sphingosine 1-phosphate lyase (spl-), suggests that this is a major component 
of PE synthesis pathway in Leishmania promastigotes. Addition of ethanolamine restored 
the wild type phenotype, indicating L. major promastigotes are unable to produce 
significant amounts of these critical phospholipids without sphingolipids. However, L. 
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major spt2- spl- amastigotes remain phenotypically normal and infective, as well as both 
SPT2 and SPL mRNA/proteins are down regulated in wild type amastigotes, indicating 
that amastigotes most likely synthesize PE using ethanolamine from other metabolic 
routes (Zhang et al., 2007). Additionally, a putative gene for phosphatidylserine 
decarboxylase (PSD), which converts PS into PE by removing carbon dioxide from the 
serine head group, has also been found in Leishmania (Figure 5; Rogers et al., 2011).  
PSD is typically an integral membrane protein and is found in most other eukaryotes 
(Schuiki and Daum, 2009). 
 Finally, any available PE, whether formed via the Kennedy pathway, breakdown 
of sphingolipids, or decarboxylation of PS, can be converted into PC by the enzyme 
phosphatidylethanolamine methyltransferase (PEMT) (Figure 5).  One or multiple PEMT 
enzymes catalyze the transfer of three successive methyl groups to the ethanolamine head 
group of PE to form PC, using S-adenosyl methionine as a methyl group donor (Vance, 
2014).  PEMT is found in most eukaryotes and two PEMT enzymes, PEM1 and PEM2, 
have very recently been experimentally characterized in L. major.  In vitro enzyme assays 
using protein purified from recombinant Leishmania showed expression and activity were 
highest in mid-log growth stage promastigotes and lowest in macrophage cell-invasive 
amastigotes.  Identification of an endoplasmic reticulum (ER) retention amino acid 
sequence, as well as studies using in vivo immunofluorescence and fractionation with the 
detergent Digitonin, indicated that both PEMT enzymes are integral membrane proteins 
that localize to the ER.  Analysis of cellular lipids using electrospray ionization tandem 
mass spectrometry from a variety of recombinant mutant S. cerevisiae yeast strains 
showed that expression of Leishmania PEM1 and PEM2 rescued a phenotype in which 
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exogenous choline was required in yeast double null mutants.  These experiments were 
also used to show the extent to which each PEMT enzyme catalyzes each successive 
methylation reaction. PEM1 forms monomethyl-phosphatidylethanolamine (MMPE) and 
dimethyl-phosphatidylethanolamine (DMPE), while PEM2 forms DMPE and PC (Figure 
5).  Finally, it was shown that both PEMT enzymes were inhibited by several choline 
analogs including miltefosine (Bibis et al., 2014).   
 
 
 
Figure 5. Major Pathways of Phospholipid Synthesis in Leishmania.  This flow chart 
shows the major routes for synthesis of PC, PE, and PS in Leishmania.  Putative enzymes 
of which candidate genes have been identified in the Leishmania genome, but not 
characterized, are shown in black, while enzymes that have been experimentally 
characterized are shown in red.  
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CTP: Glycerol-3-Phosphate Cytidylyltransferase as a Model Enzyme 
The cytidylyltransferase family describes a group of enzymes that utilize CTP as a 
substrate to attach to another substrate with a free hydroxyl group.  CTP: glycerol 3-
phosphate cytidylyltransferase (GCT) from the bacterium Bacillus subtilis is the best 
characterized member of the cytidylyltransferase family. GCT catalyzes the addition of 
CTP to glycerol-3-phosphate to yield CDP-glycerol and inorganic pyrophosphate as 
byproduct.  CDP-glycerol is eventually converted to teichoic acid, a polysaccharide 
needed for synthesis of gram positive bacterial cell walls (Park et al., 1993). GCT is, on 
average, the smallest enzyme of the cytidylyltransferase family, with B. subtilis GCT 
having just 129 amino acids and a molecular mass of 28 kDa (Weber et al., 1999).  Due 
to its small structure, GCT has become the model enzyme for studying the structure and 
function of cytidylyltransferases, including CCT and ECT.  Amino acid sequence 
alignment of GCT, CCT, and ECT indicates the members of the cytidylyltransferase 
family have two highly conserved amino acid sequences, denoted HxGH and RTxGxST, 
that are believed to be necessary for catalysis (Figure 6; Weber et al., 1999, Fong et al., 
2006, Lee et al., 2009).  In vitro enzyme assay of site directed mutants showed that H14A 
and H17A, found in the HxGH region, as well as D11A, D38A, R55A, D66A, H84A, and 
D94A all but eliminated the activity of the enzyme compared to wild type.  Also, R113A, 
T114A, S118A, and T119A, found in the RTxGxST region, all decreased GCT activity to 
less than 10% of wild type level (Park et al., 1997).  
  The three dimensional crystal structure of B. subtilis GCT was the first in the 
cytidylyltransferase family to be solved.  These initial GCT crystal structures have 
provided a glimpse into the relationship between structure and catalysis, as GCT was 
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observed to be a dimer wherein each monomer folds into a single globular catalytic 
domain containing five alpha helices and five beta sheets (Weber et al., 1999).  
Additionally, crystal structures showing B. subtilis GCT bound to CDP-glycerol product 
have identified T9, F10, H17, K44, K46, W95, and R113 as critical active site amino 
acids (Figure 6; Pattridge et al., 2003).  All of these active site residues have either 
identical or functionally similar counterparts found in the same three-dimensional 
orientation in the crystal structure of the catalytic domain of rat CCT bound to CDP-
choline product (Figure 9; Lee et al., 2009). 
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Figure 6. Amino Acid Sequence Alignment of CCT, GCT, and ECT.  Rat CCT 
(accession NP_511177), B. subtilis GCT (accession AAB27724), and Rat ECT 
(accession NP_446020) are aligned using Clustal Omega and BoxShade programs.  
Amino acids highlighted in grey represent those that are similar, and those highlighted in 
black are identical.  Also, amino acids highlighted in blue are active site amino acids 
identified from crystal structures, and those highlighted in red are known to be necessary 
for catalysis. 
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Structure and Function of CTP: Phosphocholine Cytidylyltransferase 
 CCT catalyzes the addition of cytidine triphosphate (CTP) to phosphocholine, 
yielding CDP-choline and inorganic pyrophosphate byproduct (Figure 4, 5).  CCT is the 
most extensively studied of the cytidylyltransferase enzymes and has been characterized 
from a variety of organisms including human, rat, the yeast S. cerevisiae, the model plant 
Arabidopsis thaliana, the fly Drosophila melanogaster, the nematode Caenorhabditis 
elegans, and the protozoan Plasmodium falciparum (Kalmar et al., 1994; Friesen et al., 
1999; Friesen, Park, and Kent, 2001; Helmink and Friesen, 2004; Tilley et al., 2008; 
Friesen, Liu, and Kent, 2001; Yeo et al., 1997).  Past studies using amino acid sequence 
alignment, mutagenesis, and enzyme-specific proteolysis have indicated that there are 
three main functional regions within CCT isoforms; an amino terminal catalytic domain, 
a membrane binding region, and a phosphorylated carboxy terminal domain (Figure 7; 
Kent, 1997). 
 
 
Figure 7. Functional Domains of CCT.  Amino acid sequence of rat CCTα showing a 
possible nuclear localization signal highlighted in blue, the catalytic domain highlighted 
in green, the membrane binding domain highlighted in yellow, and phosphorylation 
domain highlighted in purple. 
 
The catalytic domain of CCT contains the highly conserved HxGH and RTxGxST 
regions in primary sequence. While considering the previously discussed mutations of 
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GCT to inform relationship between structure and function in CCT, K122 and R196 were 
identified as important functional residues in rat CCT (Figure 6, 9).  In this study, three 
mutant enzymes were assayed; K122A, K122R, and R196K. K122A only maintained 
0.30% wild-type activity while K122R only retained 0.09% wild-type activity. Also, both 
lysine mutants showed significant increases in Km values with respect to phosphocholine, 
which led to the conclusion that K122 is involved in the coordination of phosphocholine 
within the active site.  Kinetic assays of R196K revealed 24% retention of wild-type 
activity while the Km for CTP was 30 times higher.  This study, coupled with structural 
information from the crystallization of GCT bound to CTP, indicated that R196 is 
involved in the coordination of CTP.  In summary, these findings lead to the conclusion 
that K122 and R196 both play a significant role in the substrate binding process by 
providing necessary charge and steric stabilization (Helmink et al., 2003).  This was 
proven when the crystal structure of the truncated, nuclear isoform CCTα from the rat 
Rattus norvegicus was solved.  Analysis showed a globular dimeric structure, with each 
monomer containing six alpha helices and five beta sheets (Figure 8). 
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Figure 8. Three Dimensional Structure of Rat CCT236α Bound with CDP-choline.  (A) 
Frontal view orientation of homodimer, shown in gray, bound with CDP-choline, shown 
in CPK colors.  (B) Right side view of monomer, with α helices shown in purple and β 
sheets shown in green.  Bound CDP-choline shown in CPK colors.  Both images 
constructed using PDB 3HL4 coordinate file in Rasmol. 
 
 
 
In the CCTα monomer, amino acids 1-236 comprise the catalytic domain, 237-
314 are the membrane binding region, and 315-367 makes up the phosphorylated domain 
(Figure 7).  The truncated version of rat CCTα, named CCT236, contained only the first 
236 amino acids (the catalytic domain) due to limited solubility caused by the membrane 
binding domain in aqueous solution.  As previously alluded to in GCT, the three-
dimensional structure of rat CCT236 bound to CDP-choline has identified I84, F85, H92, 
K122, H168, Y173, and R196 as critical active site residues (Figure 9; Lee et al., 2009).  
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Figure 9. Three Dimensional Structure of Rat CCT236α Active Site.  Structures shown in 
CPK colors with critical active site residues shown in smaller thickness and bound CDP-
choline product shown in greater thickness.  Interaction distances between atoms are 
scaled proportionally. 
 
 
 
The membrane binding domain of CCT is responsible for regulating its activity 
through reversible association with membranes. While known to contain a large 
concentration of hydrophobic amino acids and perform the same function in mammals, 
yeast, C. elegans, and P. falciparum, the primary amino acid sequence identity is not 
highly conserved. Central to this regulatory function is the property that mammalian CCT 
is present as both a soluble and a membrane-associated form within the cell, as shown by 
protein purification. In isolation, the membrane binding domains from rat and C. 
elegans have little secondary structure, based on circular dichroism analysis, but form an 
alpha helix upon membrane binding (Friesen, Liu, and Kent, 2001). Synthetic peptides 
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identical to the membrane binding domain from rat and P. falciparum show a similar 
transformation induced by membrane binding (Larvor et al., 2003).  The formation of this 
amphipathic alpha helix activates the enzyme and increases the rate of PC synthesis.  For 
example, in the absence of lipids, the full-length rat CCTα was shown to have very low 
catalytic efficiency and a Km value for CTP that is 100 times higher than the average 
cellular concentration. Binding to anionic lipids significantly increases the catalytic 
efficiency and lowers the Km value for CTP (Ding et al., 2012).   
Experiments with rat and C. elegans CCT isoforms identified the membrane 
binding domain amino acids and postulated that it is responsible for inhibition of the 
enzyme.  C. elegans CCT was truncated after amino acids 319, 281, 266, 245, or 225. 
Comparison of these five truncations to full-length wild-type CCT in the presence of PC 
vesicles containing the fatty acid oleate (1:1 PC:oleate) showed that the two shortest 
proteins were maximally active regardless of the amount of lipid available.  Thus, it was 
concluded the CCT245 and CCT225 are both truncated before the membrane binding 
domain. The fact that CCT245 activity was not dependent on lipid availability, unlike 
CCT266, suggested that the amino acids between 246 and 266 were involved in the 
activation of the enzyme through association with the lipids of a cell membrane (Friesen, 
Liu, and Kent, 2001).   
A more recent study utilized site directed mutagenesis to find which individual 
amino acids in this region were responsible for membrane binding.  L246S, W249S, 
I256S, I257S, and F260S mutants demonstrated low activity in the absence 
of lipid vesicles, similar to wild-type CCT.  However, lipid stimulated activity was 
markedly reduced compared to wild-type.  Mutational analysis of F260 implicated this 
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residue as a contributor to auto-inhibition of CCT due to activity of the F260S mutant 
being higher than wild type in the absence of lipid vesicles.  Mutation of L246, W249, 
I256, and I257 simultaneously to serine resulted in significantly higher activity compared 
to wild type in the absence of lipid vesicles and an enzyme that was not lipid activated, 
implicating the entire region as being auto-inhibitory in aqueous solution (Braker et al., 
2009).  It is largely unknown whether this region contributes to auto-inhibition in the 
absence of membrane lipids is due to a lack of structural rearrangement or actual binding 
interaction with the catalytic site.  Nonetheless, a very recent study in rat CCTα has 
shown that as much as 100 times amount of membrane binding peptide compared to a 
catalytic truncation was not able to decrease activity in the absence of lipids, suggesting 
the lack of a strong interaction with the catalytic domain (Ding et al., 2012).    
The presence of a nuclear localization signal (RKRRK) on the amino terminal 
side of the catalytic region is found in CCT isoforms that localize to the nucleus, 
including mammalian CCTα (Wang et al., 1995).  However, recent studies have revealed 
the presence of another isoform of CCT in mammals, denoted CCTβ.  CCTα was shown 
to be located in the nucleus while CCTβ was determined to be a cytosolic isoform using 
immunofluorescence (Lykidis et al., 1998).  D. melanogaster also contains two CCT 
isoforms, CCT1 and CCT2, which have been recently characterized by a past member of 
the laboratory. Intracellular visualization of each CCT isoform was accomplished by 
confocal microscopy using carboxy-terminal green fluorescent fusion proteins and CCT1 
was shown to be located in the nucleus, while CCT2 was cytosolic (Tilley et al., 2008). 
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Structure and Function of CTP: Phosphoethanolamine Cytidylyltransferase 
 ECT catalyzes the addition of cytidine triphosphate (CTP) to 
phosphoethanolamine, yielding CDP-choline and inorganic pyrophosphate byproduct.  
ECT has not been studied as extensively as CCT, as concentration of PE in most 
eukaryotic cell membranes is much less than PC (Murphy et al., 1992; Kaneko et al., 
1976; Zhang and Beverley, 2010).  Analysis of amino acid sequences of ECT from 
human, rat, and yeast reveals a significant difference in the domain structure of the 
enzyme in comparison to CCT and GCT. It has been observed that CCT and GCT 
isoforms have a single HxGH site and, therefore, a single active site per polypeptide 
chain, while ECT isoforms have two HxGH sites.  This observation suggests ECT may 
have two catalytic domains within a single polypeptide. Despite the duplication of the 
HxGH site, ECT isoforms typically have just one complete RTxGxST site in the amino 
terminal half of the sequence, leading to the possibility that the carboxy terminal half of 
the protein may not contain a fully functional catalytic site.  Also, the carboxy terminal 
end of typical ECT isoforms does not appear to have the same membrane binding domain 
as found in CCT (Bladergroen et al., 1999).   
 Additionally, older studies using centrifugation of liver homogenates and cDNA 
from rat liver cells determined that ECT and CCT activity were separate, and that, unlike 
CCT, the ECT isoform from this organism was entirely cytosolic and not regulated by 
addition of exogenous lipids in vitro (Vermueulen et al., 1993). An isoform of ECT from 
bloodstream Trypanosoma brucei, a parasite closely related to Leishmania, has also very 
recently been characterized.  Studies using immunofluorescence showed that T. brucei 
ECT, much like the mammalian isoform, localized to the cytosol (Gibellini et al., 2009).   
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 However, studies in Chlamydomonas reinhardtii, a single-celled green algae, 
provide a less complex view of PE metabolism as PC and PS are not present in this 
organism.  Analysis of amino acid sequence alignment with isoforms from rat, human, 
and yeast show that C. reinhardtii ECT contains a unique amino terminal sequence of 50 
amino acids not found in the other isoforms.  This amino terminal sequence contains a 
subcellular localization sequence for mitochondrial targeting, as well as significant 
hydrophobicity, and the capability to form and amphipathic α-helix.  Differential 
centrifugation and comparison with known marker enzymes showed that C. reinhardtii 
ECT is bound to the outer membrane of the mitochondria (Yang et al., 2004).  Similarly, 
an ECT isoform from the castor bean Riccinus communis L endosperm was also shown to 
localize to the mitochondria, as well as be slightly activated by a mixture of 
phospholipids (Wang and Moore, 1991). These results indicate that ECT localization 
between the cytosol and mitochondria may be a difference between mammalian (or 
residing therein) and photosynthetic organisms.   
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Summary of Goals 
  CCT is an attractive potential drug target for leishmaniasis due its regulatory 
activity in the de novo synthesis of phosphatidylcholine in the Kennedy pathway (Figure 
4).  This is strengthened by the hypothesis that the Kennedy pathway may be the 
predominant route for PC synthesis in infective amastigotes, as PEMT activity in these 
cells is nearly non-existent and the Leishmania cell would have a wealth of access to 
choline within the mammalian host (Bibis et al., 2014).  Characterizing the biochemical 
properties of the enzyme from L. major is the first step of understanding how CCT 
functions.  First, recombinant DNA encoding the CCT protein from L. major will be 
cloned into E. coli cells and the protein will be produced by inducible expression.  
Purification of the protein will be accomplished using affinity column chromatography 
and a series of isolating washes.  Purified CCT enzyme will then be used to catalyze the 
addition of CTP and [14C] phosphocholine to form [14C]CDP-choline, which will be 
isolated and quantified in a radioisotope scintillation assay.  Assay of varying 
concentrations of CTP and [14C] phosphocholine will determine the maximal velocity 
(Vmax) and substrate constant (Km) for each substrate, while CCT activity will also be 
assessed in the presence of various divalent metal cations, and at different temperature 
and pH.  The work performed will hopefully provide the scientific community with a 
better understanding of the properties of the Leishmania CCT, so that in the future more 
specific pharmaceuticals and effective dose regimes can be designed to treat 
leishmaniasis by inhibiting this enzyme. 
 Also, amino acid sequencing will be used to identify critical catalytic residues and 
possible membrane binding domains in CCT.  The gene for CCT will be recombinantly 
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expressed with mCherry red fluorescent protein (RFP) as a fusion protein construct in 
non pathogenic L. tarentolae.  Subcellular localization of the mCherry tagged fusion 
protein will then be visualized using confocal microscopy.  This will determine the 
intracellular localization of Leishmania CCT which is currently unknown, although other 
isoforms have been individually shown to localize to the nucleus and throughout the 
cytosol (Wang et al., 1995; Lykidis et al., 1998; Tilley et al., 2008).  Also mentioned 
previously, an isoform of ECT from L. major has been characterized by a previous 
member of the lab in an unpublished study (Morganthaler, 2014).  This work mostly 
identifies its kinetic parameters and activity in the presence of various divalent metal 
cations.  Although previous studies in other organisms suggest the cytosol and or 
mitochondria as probable targets, ECT localization within the Leishmania cell remains 
undetermined (Vermueulen et al., 1993; Gibellini et al., 2009; Yang et al., 2004; Wang 
and Moore, 1991).  Knowledge of the subcellular localization of both CCT and ECT in 
Leishmania promastigotes would not only provide insight into organelle specific 
allocation of PC or PE synthesized by the Kennedy pathway, but would also yield 
information useful in synthesis of an inhibitors that might be used as a possible 
therapeutic for leishmaniasis.   
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CHAPTER II 
EXPERIMENTAL METHODS 
Amplification of Leishmania Genes by Polymerase Chain Reaction 
 The polymerase chain reaction (PCR) was used to amplify the full length gene 
encoding Leishmania major CCT (Genbank ID: XM_001682490), a truncation after the 
1267 bp position, the full length gene encoding Leishmania major ECT (Genbank ID: 
CAJ08605), and the RFP gene, mCherry. A PCR reaction mixture was made containing 5 
µL of 100 µM forward and reverse single-stranded oligonucleotide primers (Sigma-
Aldrich), flanking the 5’ and 3’ ends of the gene respectively, that were used to amplify 
the L. major enzyme genes from genomic DNA or the mCherry gene from a Hto-RFP 
plasmid (courtesy of Dr. Kevin Edwards, Illinois State University) (Table 1).  
 
Table 1 
Kinetics Experiment Primer Sequences and Restriction Sites 
Name Oligonucleotide Sequence Restriction 
Enzyme 
LmCCT5 5’-ATCTAGGATCCCATGCCGCATCTGCTT 
GAGC-3’ 
 
BamHI 
LmCCTtr5 5’-ATCTAGGATCCCATGCTGGTGGACTTG 
TCGTAC -3’ 
 
BamHI 
LmCCT3 5’-ATCTACTCGAGTCATGCCCCGTCCTTCACC-3’ XhoI 
 
Note. Forward (5’) and reverse (3’) oligonucleotide primer sequences are listed.  Start 
codons are noted in green and stop codons are noted red (reverse complement). 
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 The mixture also contained 400 µL of water, 15 µL of 10 mM deoxynucleotide 
triphosphate (dNTP) mixture, 50 µL of 10x Pfx amplification buffer, 25 µL of 10x PCRx 
enhancer solution, and 1 µL of Platinum® Pfx DNA polymerase (Invitrogen).  Then, 96 
µL of the master mix was added to four separate tubes containing 1, 2, 4, and 8 µL of 50 
mM MgSO4.  These reaction tubes were amplified using a PTC-200 DNA Engine 
Thermal Cycler PCR on a cycle of three temperatures (94ºC for 15 sec., 45ºC for 30 sec., 
and 68ºC for 1 min.) repeated 30 times. At 94ºC the double-stranded template DNA 
denatures, the primers then anneal at 50ºC, and at 68ºC the thermostable Pfx DNA 
polymerase catalyzes the elongation of a new DNA strand by incorporating new dNTPs. 
Once PCR was completed, the amplified double-stranded DNA products were analyzed 
on a 0.7% (w/v) agarose gel, purified using a PureLink™ Quick PCR Purification Kit 
(Invitrogen), and stored at -20oC. 
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Visualization of DNA using Agarose Gels 
 An agarose gel separates DNA fragments based on the length of nucleotides. 
Using a microwave oven, a mixture of 0.7% (w/v) agarose was heated in 0.5x TBE (44.5 
mM Tris, 44.5 mM boric acid, 1 mM EDTA) until dissolved. SBYR safe (Invitrogen) 
was added to the hot mixture in a 5 µL per 100 mL ratio. SYBR safe is a fluorescent 
molecule that intercalates into DNA and allows for the visualization of DNA when UV 
light strikes the gel. The warm mixture was placed into a plastic mold and allowed to 
cool to room temperature before use. DNA samples were prepared for analysis by adding 
5 µL of 5X loading buffer (Promega) to 20 µL of each sample yielding a final 
concentration of 1x, which adequately allows for visualization of samples as they run 
towards the anode in the gel. Once the samples were prepared, they were loaded into the 
wells of the gel and the DNA fragments separated at 150 V for approximately 30 min. 
Gels were imaged using a Kodak Gel Logic 200 Imaging System. 
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Cloning of the Amplified Leishmania Genes into a Plasmid Expression Vector 
 After the CCT, CCTtrun, and ECT genes were amplified, they were placed into 
two separate plasmid expression vectors. These plasmids contain several restriction 
enzyme sites in a multiple cloning site that are used to remove sections of the original 
plasmid and replace them with DNA amplified by PCR. The restriction enzyme sites 
utilized for the cloning of L. major CCT and CCTtrun into pET45b were BamHI and 
XhoI (New England Biolabs) (Table 1, Figure 10).  
 
 
Figure 10. Plasmid Map of pET-45b.  The BamHI (237) and XhoI (176) restriction sites 
within the multiple cloning site were used to clone the genes of interest.  Upstream of the 
5’ cloning site is the 6x histidine tag (His Tag).  The plasmid also contains an ampicillin 
antibiotic resistance gene.   
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 A restriction digest was performed to cut the pET45b plasmid vector by 
incubating 5 µL of pET45b, 2 µL of 10x NEB buffer #2, 0.5 µL of BamHI, 0.5 µL of 
XhoI, and 12 µL of water at 37oC overnight.  Separate restriction digests were also 
performed to cut the PCR amplified CCT and CCTtrun gene insert fragments.  Both the 
plasmid vector and insert DNA fragments were run on a 0.7% agarose gel, excised, and 
purified using the PureLink™ Quick Gel Extraction Kit (Invitrogen).  The digested CCT 
and CCTtrun gene inserts were both separately ligated into pET45b by incubating 8.5 µL 
of insert (CCT or CCT trun) with 8.5 µL of pET45b plasmid vector, 2 µL of 10x buffer 
with 10 mM ATP, and 1 µL of T4 DNA ligase (New England Biolabs) at 15oC overnight.  
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Transformation of Competent E. coli 
 Transformation is a process in which plasmid DNA is taken up by competent 
bacterial cells. Separate mixtures of 50 µL of  dam- dcm- strain of E. coli cells (New 
England Biolabs) and 5 µL of either pET45b-CCT or pET45b-CCTtrun plasmid DNA 
were incubated for 30 min. on ice.  Next, the mixture was heat shocked for 1 min. at 37oC 
and placed on ice for 2 min.  The mixture was then added to 1 mL of Luria Broth (LB) 
media and incubated at 37oC for 1 hr.  The mixture was then plated on LB agar plates that 
contained 100 µg/ml ampicillin and incubated at 37oC overnight in order to select for 
growth of transformed cells by way of the plasmid ampicillin resistance gene. A variety 
of colonies were selected from the plates and grown at 37oC overnight in LB media 
containing 100 µg/ml ampicillin. The replicated plasmid DNA was then purified from the 
cell culture using a PureLink™ Quick Plasmid Miniprep Kit (Invitrogen). A small 
amount of the purified plasmid DNA was then digested with the restriction enzymes 
BamHI and XhoI as previously described.  Finally, the resulting DNA fragments were 
analyzed using a 0.7% agarose gel to determine if the fragments matched the size of the 
inserted CCT and CCTtrun genes. Purified plasmid DNA that yielded correctly sized 
fragments was stored at -20ºC. 
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DNA Sequencing of Inserted Leishmania Genes 
 DNA sequencing was carried out using a kit obtained from Applied Biosystems. 
Sequencing of the LmCCT and LmCCTtrun genes utilized two primers, a T7 promoter 
primer (5’-TAATACGACTCACTATAGGG-3’) that annealed upstream of the Bam HI 
site or a T7 terminator primer (5’-GCTAGTTATTGCTCAGCGG-3’) that annealed 
downstream of the XhoI site. A sequencing reaction was prepared by mixing 2 µl of 
purified plasmid DNA with 1 µl Big Dye Terminator 5X buffer, 1 µl Big Dye Terminator 
Ready Mix® and 1 µl of 1 µM T7 forward promoter primer or 1 µM T7 terminator 
primer. The mixtures were placed in the thermal cycler and subjected to 25 cycles of 
96ºC for 10 sec., 50ºC for 5 sec., and 60ºC for 4 min. The contents of the PCR tubes were 
mixed with 25 µL of 95% ethanol, 1 µL 3 M sodium acetate pH 5 and 1 µL 125 mM 
EDTA. The samples were incubated at room temperature for 15 min. before being 
centrifuged at 16000 x g for 20 min. The supernatant liquid was removed and 35 µL of 
70% ethanol was added to wash the DNA. The samples were vortexed for approximately 
5 sec. and centrifuged for 5 min. at 16,000 x g. The wash liquid was removed and the 
samples were dried at 16,000 x g for 5 min. using a speedvac.  
 The dried DNA samples were analyzed using capillary electrophoresis on a 3130 
Genetic Analyzer (Applied Biosystems®) operated by a technician in the School of 
Biological Sciences. The Ready Reaction Mix® contains a thermostable DNA 
polymerase, deoxynucleotides (dNTPs), and fluorescently labeled dideoxynucleotides 
(ddNTP). Each ddNTP emits a different color light when excited. When the polymerase 
attaches a ddNTP, the polymerization reaction comes to a stop. During the 25 cycles, the 
polymerase will attach a ddNTP at every nucleotide position in the gene under 
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investigation, giving rise to a ladder of DNA fragments varying in size by one nucleotide. 
Capillary electrophoresis separates these fragments based on size, and a laser excites the 
fluorescent dyes which emit a photon that is captured by a detector and transmitted to a 
monitor to create a chromatogram.  
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Low Temperature Protein Expression and Production 
 The pET45b-LmCCT and pET45b-LmCCTtrun purified plasmid DNA was used 
to transform competent Arctic Express (DE3) RIL E. coli cells, as described previously, 
for production of recombinant full length and truncated L. major CCT protein.  These 
cells were chosen after protein production using standard BL21 E. coli failed and 
cultivation of protein by lowering temperature, and subsequently expression level, was 
thought to be the solution.  
 The term “Arctic Express” arises from the fact that these cells contain a pACYC-
based plasmid encoding the chaperonin proteins Cpn10 and Cpn60, as well as a 
gentamycin resistance gene.  Cpn10 and Cpn60 are cold-adapted chaperonin proteins 
from the psychrophilic bacterium Oleispira antarctica, which facilitate the correct 
folding of proteins with significant hydrophobic character at lower temperatures between 
4-12oC.   DE3 denotes the E. coli contain a gene which expresses the T7 RNA 
polymerase from the lacUV5 promoter upon induction by isopropyl-1-thio-β-D-
galactopyranoside (IPTG).  This polymerase then binds to the T7 promoter on the 
pET45b vector and initiates RNA synthesis of the target gene.  As their name implies, 
these cells also contain a pSC101-based plasmid cloned with extra copies of the argU 
(R), ileY (I), and leuW (L) tRNA genes, as well as a streptomycin resistance gene.  These 
additional tRNAs facilitate expression of proteins encoded by rare codons in E. coli that 
are found more frequently in Leishmania.  
 Following transformation, these cells were plated on LB agar plates containing 
100 µg/ml ampicillin, to maintain the expression plasmid, and grown overnight at 37oC.  
A colony from the transformation plate was selected and added to 100 mL of LB broth 
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containing 100 μg/ml of ampicillin and 20 µg/ml of gentamycin, to maintain the 
chaperonin plasmid, and the cells were grown overnight in a 37oC incubator/shaker at 
250 rpm. The following day, the cells were transferred into a flask with 1 L of LB media 
containing no selection antibiotics and grown for 3 hrs. at 30oC with 250 rpm shaking.  
The 1 L culture was then transferred to a hot plate in the cold room to incubate and stir.  
Once the culture equilibrated to 10-13oC, 100 mg IPTG (Sigma) was added to induce 
production of CCT and CCT trun protein.  The cell culture was then allowed to grow for 
72 hrs. Finally, the 1 L cell culture was split into 250 mL portions, harvested by 
centrifugation in an Avanti™ J-251 centrifuge (Beckman) at 5,000 rpm (4,650 x g) for 5 
min., and stored at -20oC.  
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Protein Purification using Immobilized Metal Affinity Chromatography 
 After growth of the cells expressing the enzyme, the cells were centrifuged and 
resuspended in 20 mL of lysis buffer containing 50 mM Tris and 100 mM NaCl at pH 
7.5. To obtain the enzyme from the E. coli cells, the cell resuspension was placed under 
high pressure at 1000 psi in a French Press (SLM-AMICO) and then moved to 
atmospheric pressure.  This caused the cells to rupture and produce a crude cellular 
extract. A 500 µL aliquot of protease inhibitors (Sigma) were added to the E. coli cells 
before rupturing to prevent degradation of the desired protein. The lysed cellular extract 
was centrifuged at 15,000 rpm (31,000 x g) for 20 min. to separate the desired, soluble 
supernatant fluid from the insoluble pellet material.  
 The supernatant liquid was then incubated with 1 mM ATP and 1 mM Mg2+ for 
30 min. at 28oC in order to dissociate bound chaparonin proteins.  The solution was then 
passed through a column (13 cm height, 1.8 cm diameter) packed with 3 mL HisPur™ 
cobalt affinity resin (Thermo), which contains cobalt(II) ion that binds to the 6x histidine 
tag located on the amino terminal end of the recombinant protein. The column was 
washed once with 50 mL of lysis buffer to remove non-bound proteins.  The column was 
then resuspended in 10 mL of lysis buffer containing 5 mM ATP, 5 mM Mg2+, and 20 
mM imidazole, and incubated again for 30 min. at 28oC to remove any remaining 
chaperonin protein. After draining, the column was washed with 50 mL of lysis buffer 
and 20 mM imidazole to remove any proteins with significant histidine character. The 
full length and truncated CCT protein was eluted from the column by using 10 mL of 
lysis buffer containing 200 mM imidazole and collected in 500 µL aliquots. The side 
chain of histidine contains an imidazole ring, therefore the imidazole competes with the 
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6x histidine tag for binding to the immobilized cobalt. Once the histidine was released 
from the cobalt, the CCT protein was released from the column. 
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Determination of Protein Concentration by Method of Bradford 
 The Bradford assay was employed to determine the concentration of protein in the 
crude cellular extract, supernatant, and column elution fractions.  This method uses a Bio-
Rad reagent that binds to the proteins and changes from the cationic form to the neutral 
form which absorbs light at a wavelength of 595 nm (Bradford, 1976).  A standard curve 
was completed using known concentrations of bovine serum albumin (BSA) that was 
used to solve for unknown protein concentrations. The Bio-Rad reagent is a 5x solution, 
meaning it must be diluted fivefold in the prepared sample. When using 1000 µL as the 
total volume, 200 µL of Bio-Rad reagent was added. The other 800 µL is a mixture of 
water and protein sample. The unknown samples should have an absorbance somewhere 
between the most concentrated and least concentrated standard. Once the unknown 
samples were prepared, the absorbance at 595 nm was determined and this was used to 
find the mass of protein (µg) in the sample according to the standard curve.  The 
concentration (µg/µL) could then be found by dividing this mass by the volume of 
purified protein used in the sample (µL). 
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Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a 
procedure for separating proteins based on molar mass. The polyacrylamide gel consists 
of a mixture of acrylamide, bis acrylamide, tetramethylethylenediamine (TEMED), 
buffers, water, and ammonium persulfate. TEMED generates free radicals from 
ammonium persulfate that promote production of free radical acrylamide monomers 
which react with non-radical monomers causing polymerization. Acrylamide polymers 
crosslink with bis acrylamide creating a mesh work of polymers that causes the 
separation of proteins based on mass.  Typically 12% (v/v) acrylamide was used, but the 
percentage was increased or decreased based on the mass of the protein to be analyzed.  
 Sample preparation for SDS-PAGE involved diluting protein samples to 1 µg/µL 
with water to a final volume of 75 µL, adding 25 µL of 4x SDS dye (270 mM SDS, 6 
mM bromophenol blue, 200 mM Tris-HCl, 400 mM DTT, 40% (v/v) glycerol) to a final 
concentration of 1x in 100 µL, and boiling the samples for 5 min.  This causes denaturing 
and allows negatively charged SDS molecules to evenly coat the protein. The samples 
and a set of standards of known molar mass were loaded onto the gel. The proteins were 
then separated at 200 V for 50 min. After electrophoresis, the gel was incubated in a 
0.1% (w/v) staining solution of coomassie blue dye dissolved in 45% (v/v) methanol and 
10% (v/v) acetic acid for 20 min.  The gel was destained to remove stain not bound to 
protein by incubating the gel in a solution of 45% (v/v) methanol and 10% (v/v) acetic 
acid. Comparing the migration of the standard proteins to the unknown samples allowed 
for estimation of the molar mass of the proteins in the elution fractions and identification 
of CCT and CCTtrun.  
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Western Blot Immunoassay 
 Western blot immunoassay was used to track the desired protein throughout the 
affinity column purification fractions. Western blots are performed by first separating a 
protein mixture on an SDS-PAGE gel followed by protein transfer to a polyvinylidene 
difluoride (PVDF) membrane. A WesternBreeze® kit (Invitrogen) was used for Western 
blot development using the following procedure. The membrane was first treated with a 
blocking solution consisting of milk proteins, saline, and detergent for 30 min. to prevent 
non-specific binding of the primary antibody.  Next, the membrane was subjected to 2 
washes, 5 min. each, with ultra-filtered water.  The primary mouse anti-His antibody 
(Invitrogen), diluted 1:20,000 in blocking solution, was then incubated with the 
membrane for 1 hr. The mouse anti-His antibody binds specifically to the 6x histidine tag 
found at the amino terminus of the desired protein. The membrane was washed 4 times 
for 5 min. each with an antibody wash solution from the kit to remove any primary 
antibody weakly bound to the PVDF membrane. A goat anti-mouse IgG secondary 
antibody conjugated to alkaline phosphatase was then incubated with the membrane for 
30 min. at room temperature. This goat antibody has specificity for the primary mouse 
antibody, thus increasing sensitivity of the blotting procedure.  The membrane was 
washed 4 times for 5 min. each with the antibody wash solution and 3 times for 5 min. 
each with ultra-filtered water before the chromogenic substrate was added. The 
chromogenic substrate contained 5-bromo-4-chloro-3-indolyl-1-phosphate (BCIP), the 
substrate for alkaline phosphatase, and nitro blue tetrazolium (NBT), which produces 
color when the BCIP is digested by the enzyme. Purple bands on the membrane 
corresponded to 6x-His tagged CCT and CCTtrun protein.  
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Determination of Enzyme Activity using Radioisotope Assay 
 Enzymatic activity of CCTtrun was determined using a radioisotope scintillation 
assay previously developed in the lab for a D. melanogaster CCT isoform (Helmink and 
Friesen, 2004). This was performed by incubating CCT trun with the substrates 
phosphocholine (PoC) and cytidine 5’-triphosphate (CTP) in a solution containing 50 
mM Tris and 10 mM MgCl2 at a pH of 7.5 with a final volume of 100 µl. A small 
percentage (12.5% v/v) of the PoC is 14C-labeled, serving as a tracer to monitor 
conversion of PoC to CDP-choline. Reactions were terminated by addition of 100 µl of 
150 mM unlabeled PoC in 10% trichloracetic acid (TCA). Then, 500 µl of a 10 mg/mL 
suspension of activated charcoal was incubated with the reaction mixture for 30 min. on 
ice to bind the product CDP-choline. The charcoal was washed twice with 500 µL of H2O 
by vortexing, pelleting the charcoal at 11,000 rpm (13,500 x g) for 3 min., and decanting 
the supernatant liquid.  Finally, 500 µL of 10% (v/v) acetic acid was added to release the 
CDP-choline product from the charcoal, followed by vortexing and pelleting the charcoal 
at 11,000 rpm (13,500 x g) for 3 min.  The supernatant liquid containing CDP-choline 
was added to 5 mL of ScintiSafe 30% scintillation fluid (Fisher Scientific) and placed in 
a Beckman LS 3000 scintillation counter.  
 The scintillation counter output is in counts per minute (cpm) which was 
converted to nmol product formed/min/mg of enzyme, calculated using a formula. First, 
the background cpm, from an assay tube containing no CCTtrun activity, were subtracted 
from the experimental counts per minute. Next, the difference was divided by fraction 
recovery, assay time in min., specific activity of [14C]PoC in cpm/nmol, and amount of 
enzyme in mg. To determine fraction recovery, a tube containing no enzyme but 
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containing some cpm of [14C]CDP-choline was assayed alongside the rest of the enzyme 
samples. The scintillation counter revealed the amount of [14C]CDP-choline present after 
the assay process and these counts were termed the recovered cpm. In the final step, the 
recovered cpm were divided by the initially added cpm to yield the fraction recovery. The 
specific activity of [14C]PoC was calculated by counting a volume of [14C]PoC equal to 
the volume used in the assay. The cpm of [14C]PoC were then divided by the volume of 
[14C]PoC, in µL, and the concentration of the [14C]PoC sample, in mM. 
This quotient yielded the specific activity of [14C]PoC, which was then changed to 
cpm/nmol. Finally, the values for the recovery fraction and specific activity of PoC were 
used to find the specific activity of CCTtrun in units of nmol of CDP-choline/min/mg of 
CCTtrun enzyme.  
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Determination of Kinetic Parameters and the Effects of Divalent Metal Cations, 
Temperature, and pH on Enzyme Activity 
 The maximal velocity (Vmax) of an enzyme is the specific activity level at which 
the enzyme is saturated and the ratio of product formed per amount of enzyme remains 
the same over time.  The substrate constant (Km) is the concentration of substrate at half 
of the Vmax.  Both of these kinetic parameters were determined for CCTtrun for both CTP 
and PoC by varying the concentration of one substrate while holding the other constant.  
A concentration of 1 mM CTP was used when varying PoC concentration and 30 mM 
PoC was used when varying CTP concentration. All assays contained 5 µg of purified 
CCTtrun enzyme, buffer consisting of 50 mM Tris and 10 mM MgCl2 at a pH of 7.5, and 
water to a final volume of 100 µl incubated at 37oC for 30 min.   
 The effect of different divalent metal cations on CCTtrun activity was assessed 
using 10 mM of MgCl2, CuNO3, FeSO4, CaCl2, ZnCl2, NiCl2, MnCl2, or CoCl2 in an 
assay with 5 µg of purified CCTtrun enzyme, 1 mM CTP, 30 mM PoC, 50 mM Tris 
buffer at a pH of 7.5, and water to a final volume of 100 µl incubated at 37oC for 30 min.  
The effect of temperature on CCTtrun activity was shown using a standard assay with 5 
µg of purified CCTtrun enzyme, 1 mM CTP, 30 mM PoC, 50 mM Tris buffer at a pH of 
7.5, and water to a final volume of 100 µl incubated for 30 min. at several temperatures.  
Finally, the effect of pH on CCTtrun activity was determined using buffers of varying pH 
in a standard assay with 5 µg of purified CCTtrun enzyme, 1 mM CTP, 30 mM PoC, and 
water to a final volume of 100 µl incubated at 37oC for 30 min.  All enzyme assays were 
developed and specific activity determined as previously described.   
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Two-Step Cloning of the Amplified RFP and Leishmania Genes into a Plasmid 
Expression Vector 
The generation of expression vectors used for localization of fluorescent proteins 
by confocal microscopy required cloning using a LEXSYcon2 Expression Kit (Jena 
Bioscience).  This kit uses L. tarentolae, a non-pathogenic strain of Leishmania, for 
protein expression by transformation using the pLEXSY-sat2 plasmid vector (Figure 11). 
 
  
  
 
 
Figure 11. Plasmid Map of pLEXSY-sat2.  The BglII (1084) and KpnI (2164) restriction 
sites were used to clone the RFP gene.  The plasmid also contains a carboxy-terminal 6x 
histidine sequence.  Genes encoding β-lactamase for selective resistance against 
penicillin-type antibiotics in bacteria and encoding streptothricine acetyltransferase 
(SAT) for selective resistance against nourseothricin (NTC) in Leishmania are also 
present.  Plasmid also contains a 5’ssu and 3’ssu sites for homologous recombination into 
the Leishmania host chromosome after linearization with Swa I (5777).   
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The generation of fluorescent protein expression vectors involved two repeating 
instances of the molecular cloning, transformation, and plasmid purification previously 
described.  To summarize, the mCherry gene was amplified by PCR using the RFP5’ 
forward and RFP3’ reverse oligonucleotide primers (Table 2). 
 
Table 2 
Localization Experiment Primer Sequences and Restriction Sites  
Name Oligonucleotide Sequence Restriction 
Enzyme 
RFP5 5’-TGCAGATCTCGAGGATATCTAGAGCTA 
GCGCCATGGTGAGCAAGGGCGAG-3’ 
BglII 
XbaI 
RFP3 5’-TCGAGCGGTACCCTTGTACAGCTCGTCC 
ATG-3’ 
 
KpnI 
LmCCT25 5’-TCGAGCAGATCTGCCATGCCGCATCTG 
CTTGAGC-3’ 
 
BglII 
LmCCT23 5’-TCGAGCTCTAGATGCCCCGTCCTTCACC-3’ 
 
XbaI 
LmECT5 5’-TCGAGCAGATCTGCCATGCCCACCGTTT 
CTTCG-3’ 
 
BglII 
LmECT3 5’-TCGAGCTCTAGAGCTTGCCTCCCG-3’ XbaI 
 
Note. Forward (5’) and reverse (3’) oligonucleotide primer sequences are listed.  Start 
codons are noted in green. 
  
 
 
The mCherry insert DNA generated using PCR and the pLEXSY-sat2 vector were 
verified on 0.7% agarose gel.  The mCherry insert and pLEXSY-sat2 vector were then 
digested separately with Bgl II and Kpn I.  The mCherry insert DNA was ligated to the 
pLEXSY-sat2 vector using T4 DNA ligase. The ligation mixture was then be incubated 
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with competent DH5α E. coli cells, and successful transformation was tested by growth 
on LB agar plates supplemented with 100 mg/mL of ampicillin at 30oC.  This incubation 
temperature was decreased relative to the normal growth protocol due to minor instability 
of the pLEXSY-sat2 plasmid.  Colonies were then picked from the plates, cultured, and 
plasmid DNA was isolated.  Plasmid samples were screened for successful ligation of the 
mCherry insert by re-digestion with Bgl II and Kpn I and run on a 0.7% agarose gel.  
This entire process was then repeated using CCT and ECT insert generated by PCR from 
L. major genomic DNA and the recombinant pLEXSY-sat2-mCherry plasmid vector 
digested with Bgl II and Xba I.  As previously shown, a restriction site for XbaI was 
made in the forward RFP5’ primer and was then inserted with the ligated RFP gene into 
the pLEXSY-sat2 plasmid to allow for ligation of the L. major CCT and ECT genes to 
the 5’ end of the RFP gene (Table 2). 
 
 
 
 
 
 
 
 
48 
 
Growth and Transformation of L. tarentolae Cells 
Non pathogenic L. tarentolae were reactivated from glycerol stocks and cultured 
in 10 mL of brain-heart infusion (BHI) suspension media in a ventilated tissue culture 
flask at 26oC.  Cells were passaged in a 1:10 dilution and continually supplemented with 
50 µL of 10 µg/mL penicillin and streptomycin to prevent bacterial contamination, as 
well as 20 µL of a 0.25% solution of porcine hemin every 3-4 days.  Heme, which 
Leishmania obtain from the blood of their host in vivo, is necessary for respiration and 
the growth of these parasites as obligate aerobes.  The density, shape, and motility of 
these cells were monitored by microscopy.   
A separate restriction digest was performed to linearize the recombinant 
pLEXSY-sat2-RFP-CCT and pLEXSY-sat2-RFP-ECT expression vectors by incubating 
5 µL of each plasmid, 2 µL of 10x NEB buffer #3, 0.5 µL of SwaI, and 12.5 µL of water 
at 25oC overnight.  This linearization of the plasmid using the blunt-end cutting SwaI is 
necessary for integration of the expression cassette into the L. tarentolae chromosome by 
homologous recombination using the 5’ssu and 3’ssu sites.  Both the plasmid vectors 
were run on a 0.7% agarose gel, excised, and purified using the PureLink™ Quick Gel 
Extraction Kit (Invitrogen).   
A healthy and motile 10 mL culture of L. tarentolae cells, diluted the previous 
day, was grown to a density of approximately 6 x 107 cells/mL.  The cells were then 
centrifuged at 2,000 x g for 5 min., resuspended in half the volume of the supernatant, 
and put on ice for 10 min.  A 350 µL aliquot of cells was then added to 5 µg of pLEXSY-
sat2-RFP-CCT and pLEXSY-sat2-RFP-ECT linearized DNA in separate electroporation 
cuvettes.  The cells were electroporated at 450 V, 450 µF, and a 5 msec pulse time using 
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a GenePulser Xcell™ electroporator (Bio-Rad).  Following electroporation, the cells 
were incubated in freshly supplemented BHI media overnight.  The next day, 10 µL of 
100 mg/mL NTC was added to the electroporated culture in order to select for 
Leishmania cells that had successfully transformed and integrated the desired gene, as 
well as the SAT cassette, into their chromosome.  Successive passage and dilution 
ensured the growth of healthy, dense recombinant strains of L. tarentolae expressing 
CCT-mCherry and ECT-mCherry fusion proteins.   
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Fixing and Staining of Cells for use in Confocal Microscopy 
A 10 mL culture sample of recombinant L. tarentolae expressing CCT-mCherry 
and ECT-mCherry fusion proteins were harvested 3 days after 1:10 dilution and 
centrifuged at 2,000 x g for 5 min.  The mCherry fluorophore absorbs green light (λmax = 
587 nm) and emits red light (λmax = 610 nm).  The cells were then washed by 
resuspending in 500 µL of phosphate buffered saline (PBS) and centrifuged.  Cells were 
fixed by resuspending in 200 µL of 2% (v:v) paraformaldehyde in PBS for 20 min. and 
centrifuged.  The fixative was then washed off by resuspending in 1 mL of PBS and 
centrifuged.  The cells were permeablized by resuspending in 500 µL of 0.2% (v:v) 
Triton X-100 in PBS (PBT) for 20 min. and centrifuged.  A 200 µL amount of labeling 
solution containing SYBR green (also courtesy of Dr. Kevin Edwards) was then added to 
the cells.  The labeling solution consisted of 2 µL of SYBR green in 1 mL of PBT and 
was kept in the dark due to sensitivity to fluorescence bleaching.  SYBR green absorbs 
blue light (λmax = 497 nm) and emits green light (λmax = 520 nm) and is used to stain 
DNA, which is present in both the nucleus and kinetoplast of L. tarentolae. 
Slides were prepared for confocal microscopy by adding 5 µL of labeled cells to 
mounting media and placing between a slide and coverslip.  Recombinant cells were 
visualized using the TCS SP2 Confocal Microscope (Leica), utilizing a HCX PL APO 
63X oil immersion objective, a blue Ar 488 nm laser to see SYBR green, and a green 
DPSS 561 nm laser to see mCherry.  Lastly, images were overlaid to visualize sub 
cellular localization of both CCT and ECT within the L. tarentolae cell. 
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CHAPTER III 
RESULTS AND DISCUSSION 
Putative LmCCT and LmECT Amino Acid Sequence Alignment and Analysis  
The genome sequences of Leishmania major are available through the Sanger 
Institute (http://www.sanger.ac.uk) and were analyzed for genes involved in PC 
biosynthesis.  A putative CCT gene was identified and its encoded amino acid sequence 
was aligned with isoforms from P. falciparum, C. elegans, and the rat using the Clustal 
Omega alignment tool (http://www.ebi.ac.uk/Tools/msa/clustalo/) and BoxShade server 
(http://www.ch.embnet.org/software/BOX_form.html) (Figure 12). 
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Figure 12. Amino Acid Sequence Alignment of CCT Isoforms.  L. major CCT (accession 
XP_001682542.1), P. falciparum CCT (accession AAK11280.1), C. elegans CCT 
(accession P49583.2), and Rat CCT (accession NP_511177) are aligned using Clustal 
Omega and BoxShade programs.  Amino acids highlighted in grey represent those that 
are similar, and those highlighted in black are identical.  A possible transmembrane 
domain is highlighted in green.  A nuclear localization signal is highlighted in blue. The 
truncated portion of the protein containing the cytidylyltransferase catalytic domain is 
highlighted in yellow. 
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The L. major CCT cDNA is 1779 bp long coding for 592 amino acids.  The 
putative CCT sequence from L. major contains amino acids shown to be critical for 
catalysis by the rat isoform.  There are several conserved cytidylyltransferase sequences, 
including the 451-HxGH and 555-RTxGxST motifs and K481 shown to be critical for 
catalysis in rat CCTα (Lee et al., 2009).  The presence of the highly conserved catalytic 
region suggested that the putative CCT of L. major would be able to catalyze the 
conversion of phosphocholine and CTP to CDP-choline. However, an interesting 
observation is that the L. major isoform appears to lack the lipid binding and 
phosphorylation regions present in other CCT isoforms, suggesting it may not be 
regulated by membrane association or reversible phosphorylation.  Less noticeably, it 
lacks a nuclear localization signal, which indicated it does not localize to the nucleus in 
Leishmania, but does contain an extensive amino-terminal sequence of about 350 amino 
acids not seen in other CCT isoforms.  This region was shown to have significant 
hydrophobic character and possibly contain a transmembrane region upon analysis by 
hydropathy plot using the Kyte-Doolittle hydrophobicity index 
(http://web.expasy.org/protscale/) (Figure 13). 
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Figure 13. Hydropathy Plot of L. major CCT.  Kyte-Doolittle hydrophobicity index was 
used to construct plot, wherein more hydrophobic amino acids have more positive scores 
and more hydrophilic amino acids have more negative scores.  A window size of 19 
amino acids was also used to indicate possible transmembrane regions with a peak above 
1.8.  The vertical red line indicates position of CCT truncation mutagenesis at position 
422.    
 
 
 
The truncation mutation beginning at the 422 position was designed in order to 
clone the carboxy terminal catalytic region by itself, under the suspicion that this unique 
amino terminal region may have limited solubility and low protein expression due to its 
hydrophobic nature.  The presence of a possible transmembrane domain in this region 
also indicated that CCT might permanently localize to membranes in the Leishmania cell 
such as the endoplasmic reticulum.        
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Sequence alignment of the ECT gene from L. major also showed conservation of 
the signature cytidylyltransferase motifs, indicating the ability to catalyze the conversion 
of CTP and phosphoethanolamine to CDP: ethanolamine (Figure 14). 
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Figure 14. Amino Acid Sequence Alignment of ECT Isoforms.  C. reinhardtii ECT 
(accession AAP21826.1), rat ECT (accession NP_446020.1), L. major ECT (accession 
XP_001685405.1), and T. brucei ECT (accession XP_829470.1) are aligned using Clustal 
Omega and BoxShade programs.  Amino acids highlighted in grey represent those that 
are similar, and those highlighted in black are identical.  A possible transmembrane 
domain involved in localization to the mitochondria is highlighted in red. 
 
 
 
 The sequence of the L. major isoform, however, did not contain the 
approximately 50 amino acids found in the amino terminus of the isoform from the green 
algae C. reinhardtti.  This region forms a possible transmembrane domain that causes 
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localization to the mitochondria in C. reinhardtii, therefore its absence indicated that L. 
major ECT was likely cytosolic (Yang et al., 2004).  This is the case in the vast majority 
of ECT isoforms.  The absence of a possible transmembrane domain, as well as any 
significant hydrophobic character, was also confirmed by hydropathy plot analysis 
(Figure 15).      
 
 
 
 
 
Figure 15. Hydropathy Plot of L. major ECT.  Kyte-Doolittle hydrophobicity index was 
used to construct plot, wherein more hydrophobic amino acids have more positive scores 
and more hydrophilic amino acids have more negative scores.  A window size of 19 
amino acids was also used to indicate possible transmembrane regions with a peak above 
1.8. 
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Molecular Cloning of the Full Length and Truncated LmCCT Genes into pET45b 
 Using PCR and the specific oligonucleotide primers, DNA fragments of 
approximately 1792 bp and 526 bp, for the full length and truncated CCT gene 
respectively, were amplified from L. major genomic DNA. The estimated band size on 
the agarose gel for each insert included the actual gene sizes plus the 5’ and 3’ flanking 
regions added by the oligonucleotide primers.  In the case of both reactions, the addition 
of 2 µL of 50 mM MgSO4 allowed for the greatest amplification of DNA (Figure 16).   
 
 
Figure 16. Agarose Gels of Amplified LmCCT and LmCCTtrun PCR Products.  PCR 
was conducted using 1, 2, 4, and 8 µL of 50 mM MgSO4.  1 kb DNA ladder was used as 
the standard.  (A) The band observed at approximately 1792 bp corresponds to the 
amplified LmCCT gene.  (B) The band observed at approximately 526 bp corresponds to 
the amplified LmCCTtrun gene.   
 
 
A 
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Restriction endonuclease digestion with BamHI and XhoI of both the LmCCT 
and LmCCTtrun PCR products yielded 1776 bp and 510 bp DNA fragment inserts 
respectively. Digestion of the 5260 bp pET45b plasmid removed a 61 bp “stuffer region” 
in the multiple cloning site to give a 5199 bp vector (Figure 17).   
 
 
Figure 17: Agarose Gels of Digestion of LmCCT and LmCCTtrun PCR Products, as well 
as pET45b, with BamHI and XhoI.  1 kb DNA ladder was used as the standard.  The 
band observed at approximately 5199 bp corresponds to the digested pET45b plasmid 
vector.  (A) The band observed at approximately 1776 bp corresponds to the digested 
LmCCT insert.  (B) The band observed at approximately 510 bp corresponds to the 
digested LmCCTtrun insert. 
 
 
This facilitated ligation and formation of the recombinant plasmids pET45b-
LmCCT and pET45b-LmCCTtrun. To verify that the recombinant DNA contained the 
correct insert, plasmid DNA was purified in high concentration from 18 transformant 
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colonies grown on selection plates containing LB and ampicillin.  Each recombinant 
plasmid preparation was then subjected to another digestion with BamHI and XhoI to 
show removal of the desired insert, if present. Digestion of recombinant plasmid DNA 
purified from several colonies showed successful ligation of the correctly sized gene 
inserts. Incomplete digestion of the 6975 bp pET45b-LmCCT plasmid and 5709 bp 
pET45b-LmCCTtrun plasmid was also observed in some of these colonies.  Digestion of 
the original pET45b plasmid vector, or that which had religated with the stuffer region, 
may have occurred in colonies that failed to produce the desired insert fragment (Figure 
18).   
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Figure 18. Agarose Gel of pET45b-LmCCT and pET45b-LmCCTtrun Redigest with 
BamHI and XhoI.  1 kb DNA ladder was used as the standard.  The band observed at 
approximately 5199 bp corresponds to the digested original pET45b plasmid vector.  (A) 
The band observed at approximately 1776 bp corresponds to the digested LmCCT insert, 
which indicates successful ligation and formation of the pET45b-LmCCT recombinant 
plasmid.  The band observed at approximately 6975 bp corresponds to undigested 
recombinant plasmid.  (B) The band observed at approximately 510 bp corresponds to the 
digested LmCCTtrun insert, which indicates successful ligation and formation of the 
pET45b-LmCCTtrun recombinant plasmid.  The band observed at approximately 5709 
bp corresponds to undigested recombinant plasmid. 
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DNA sequencing verified the identity of the LmCCT and LmCCTtrun gene 
inserts and showed no discrepancy according to the published sequence. 
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Purification of Truncated CCT 
 After confirming the successful cloning of the pET45b-LmCCT and pET45b-
LmCCTtrun recombinant plasmids, these expression vectors were used to transform 
Arctic Express (DE3) RIL cells.  This particular strain of E. coli is optimized for protein 
expression using Cpn10 and Cpn60, chaperonin proteins that hydrolyze ATP to ADP to 
form a heptameric ring structure, which facilitates proper protein folding at low 
temperatures.  After sufficient growth, the cells were ruptured and the protein was 
purified using immobilized metal affinity chromatography. Unfortunately, the full length 
CCT enzyme was not able to be expressed in the cells as shown by analysis of 
purification fractions by SDS-PAGE and Western blot (Figure 19).   
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Figure 19. Analysis of Full Length CCT Purification Fractions by SDS-PAGE and 
Western Blot.  (A) SDS-PAGE analysis of consecutive purification fractions shows a 
lack of a band at approximately 67 kD, which would correspond to the full length CCT 
protein.  The band at 57 kD corresponds to Cpn60 chaperonin protein.  (B) Western blot 
analysis shows lack of detection of His-tag labeled protein, confirming the inability of the 
full length CCT enzyme to be produced. 
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However, the truncated CCT enzyme was able to be expressed, most likely due to 
an increased ability to properly fold because of the absence of the highly hydrophobic 
amino terminal region.  Initially, analysis by SDS-PAGE showed a large amount of 
Cpn60 eluting with the CCTtrun in the 200 mM imidazole fraction, suggesting that the 
two were still associated.  Previous studies of enzyme assays using recombinant 
Cpn10/60 from O. antarctica showed that nearly 100% of Cpn10/60 protein resumed its 
non-folding, double-ringed, tetradecameric, quaternary structure upon incubation with 2 
mM ATP for 30 min. at higher temperatures of at least 28oC (Ferrer et al., 2004).  Thus, 
the novel purification method for separating Cpn10/60 and CCTtrun was created by 
adding ATP (and coordinating Mg2+) to displace the ADP, which would induce the 
formation of the non-folding tetradecameric structure at high temperatures, and release 
the bound CCTtrun.  This was done in the supernatant solution in order to increase 
binding of CCTtrun by eliminating steric hindrance of the binding of the 6x His-tag of 
the protein and the Co2+ in the affinity column resin.  The column was also subsequently 
washed with ATP in order to remove any chaperonin proteins that were still bound.  
Elution with 200 mM imidazole yielded pure CCTtrun enzyme and its identity was 
confirmed by Western blot (Figure 20). 
 
 
 
 
 
 
66 
 
 
 
Figure 20. Analysis of Truncated CCT Purification Fractions by SDS-PAGE and 
Western Blot.  (A) SDS-PAGE analysis of consecutive purification fractions shows a 
band at approximately 21.5 kD, corresponding to the truncated CCT protein.  The soluble 
protein is unexpectedly seen in the pellet fraction, which may be due to a low 
concentration of misfolded protein.  The band at 57 kD corresponds to Cpn60 chaperonin 
protein.  Its presence in the column flow through, 5 mM ATP wash, and second 10 mM 
imidazole wash, as well as its absence in the 200 mM imidazole elution indicates the 
success of the novel Cpn10/60 purification method.  (B) Western blot analysis shows 
detection of His-tag labeled protein, confirming the presence of the truncated CCT 
enzyme in the 200 mM imidazole elution fraction. 
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 As a result, the column retained about 15% of total protein of the cell extract from the 
cellular supernatant, and the combined washes managed to remove about 6% of total 
protein. The most highly concentrated 500 µL elution fraction contained 0.236 mg of 
purified CCTtrun, accounting for 0.226% of total protein in the cell extract (Table 3). 
 
 
Table 3 
 
Purification of CCTtrun by Metal Affinity Chromatography 
 
Note. Purified CCTtrun was eluted from the Co2+ affinity column using 10 mL of 200 
mM imidazole and collected in 20 aliquots of 500 µL.  The sixth aliquot contained 0.236 
mg of CCTtrun enzyme, representing 0.226% of total cellular protein.  
Fraction 
Sample 
Volume (mL) 
Protein 
Concentration 
(mg/mL) 
Total Protein 
(mg) 
% 
Yield 
Crude Extract 20 5.21 104 (100) 
Supernatant 20 4.83 96.5 92.7 
Pellet 20 0.221 4.43 4.25 
Flow Through 50 1.62 80.9 77.7 
10 mM Imidazole 1 50 0.004 0.191 0.183 
+ 5 mM ATP and 5 
mM Mg2+ 
10 0.072 0.717 0.689 
10mM Imidazole 2 50 0.104 5.20 5.00 
200mM Imidazole 0.5 0.471 0.236 0.226 
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Characterization of the Kinetic Properties of Truncated CCT 
The catalytic activity of purified L. major CCTtrun was dependent on the 
concentration of substrates phosphocholine (PoC) and cytidine 5’-triphosphate (CTP) 
according to Michaelis-Menten kinetics.  Increasing concentrations of each substrate 
showed a corresponding increase in specific activity following a curve that reached an 
asymptote at the apparent Vmax where the enzyme activity was saturated.  A curve was fit 
to the data using the Hill equation.   
The Hill equation, Vo = , is a slight derivation of the Michaelis-
Menten equation wherein each term in the equation raised to the power of the “Hill 
coefficient” (n).  Thus, while showing enzyme saturation as a function of substrate 
concentration, the presence of the coefficient in the Hill Equation allows for 
determination of the level of cooperativity in the binding of each substrate.  Cooperativity 
refers to the effect that binding one molecule of substrate by the enzyme has on its 
affinity for other substrate molecules.  This may indicate the presence of multiple, and 
possibly allosteric, binding sites on the same polypeptide, and/or the presence of a 
multimeric protein with subunits containing homologous binding sites.  A Hill coefficient 
value greater than 1 indicates positive cooperativity, a value less than 1 indicates negative 
cooperativity, and a value equal to 1 indicates no cooperativity.  SigmaPlot® nonlinear 
regression analysis was used to determine the parameters of the curve fitted to the data 
using the Hill equation.  Thus, the Vmax and Km for CTP were found to be approximately 
351 nmol/min/mg and 0.0648 mM respectively, while the Hill coefficient was 2.04 
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(Figure 21 A). Also, the Vmax and Km for PoC were found to be approximately 396 
nmol/min/mg and 3.74 mM respectively, while the Hill coefficient was 0.953 (Figure 21 
B).  
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Figure 21. Substrate Dependence Curves of CTP and Phosphocholine.  Each data point is 
the average of triplicate measurements and the standard error is indicated by the error 
bars.  Hill Equation was used to fit curve to data and nonlinear regression analysis 
software was used to determine kinetic parameters.  (A) Specific activity as a function of 
CTP concentration.  (B) Specific activity as a function of PoC concentration.   
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  Data were also linearized using the double-reciprocal Lineweaver-Burk plot.  In 
this plot, the y-intercept is equivalent to the inverse of Vmax and the x-intercept represents 
the negative inverse of Km.  Using this representation, the Vmax and Km for CTP were 
found to be approximately 625 nmol/min/mg and 0.25 mM respectively (Figure 22 A). 
Also, the Vmax and Km for PoC were found to be approximately 400 nmol/min/mg and 
3.72 mM respectively (Figure 22 B).  
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Figure 22. Lineweaver-Burk Plots for CTP and Phosphocholine.  Each data point is the 
average of triplicate measurements and the standard error is indicated by the error bars.  
Apparent Vmax and Km were calculated using trendline equation.  (A) The inverse of 
specific activity as a function of the inverse of CTP concentration.  (B) The inverse of 
specific activity as a function of the inverse of PoC concentration.   
 
 
 
The kinetic parameters determined by the Hill equation nonlinear regression 
analysis were used in comparison to other CCT isoforms, with Vmax being an average of 
the two values.  However, this value was shown to be two to three orders of magnitude 
lower compared to those reported for full length CCT isoforms from other organisms 
with the exception of P. falciparum at 550 nmol/min/mg.  This may indicate a similar 
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cellular role for the enzyme, and the Kennedy pathway as a whole, in the intracellular 
parasitic lifestyle shared by these two organisms pertaining to the de novo synthesis of 
phospholipids.  The Km value utilizing CTP was less than all other isoforms but on the 
same order of magnitude as that of Dros2. The Km value utilizing PoC was greater than 
all other isoforms but on the same order of magnitude as that of Dros1 (Table 4).  These 
seemingly extreme values for Km of both substrates of the enzyme from L. major may be 
explained by a difference of substrate concentration and availability within the 
macrophage host cell.  These kinetic parameters may also be very different than those of 
the full length enzyme due to the presence of the hydrophobic amino terminal domain, 
which may allow for regulation of activity by association with membranes.   
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Table 4 
 
Kinetic Values of Various CCT Isoforms 
 
Note. Vmax and Km values for L. major CCTtrun compared to those of other isoforms 
from the rat (Friesen et al., 1999), D. melanogaster 1 (Tilley et al., 2008), D. 
melanogaster 2 (Helmink and Friesen, 2004), S. cerevisiae (Friesen, Park, and Kent, 
2001), C. elegans (Friesen, Liu, and Kent, 2001), and P. falciparum (Yeo et al., 1997).
                Km (mM) 
CCT isoform Vmax (nmol/mg/min) CTP PoC 
L. major  374 0.0648 3.74 
Rat α 25480 1.29 0.65 
D. melanogaster 1 23904 1.21 2.29 
D. melanogaster 2 2254 0.81 0.63 
S. cerevisiae 35550 1.42 0.80 
C. elegans 30166 5.2 1.6 
P. falciparum 550 10.9 0.49 
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Effect of Various Divalent Metal Cations on Truncated CCT Activity 
Cytidylyltransferases from various model organisms have been reported to use the 
divalent magnesium cation (Mg2+) as a cofactor to stabilize the negatively charged 
phosphate groups of CTP during catalysis (Kent, 1997). Nonetheless, catalytic activity of 
L. major CCT was assessed in the presence of a variety of cations, as its available 
metabolites and cofactors are unique compared to these other organisms due to its 
parasitic lifecycle. The most interesting result by far was shown by the addition of Fe2+, 
which increased the activity of CCT trun nearly five-fold compared to Mg2+.  Several 
cations afforded the CCT trun enzyme a similar level of activity; the highest being Mn2+ 
at 87%, next Co2+ at 84%, and Ni2+ at 83% compared to Mg2+.  Other divalent cations 
were either not utilized efficiently for, or possibly inhibited, catalysis; with Zn2+ at 5% 
and Ca2+ and Cu2+ showing no activity compared to Mg2+.  This was very similar to the 
negative control which contained no divalent cation and showed no activity (Figure 23). 
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Figure 23. Specific Activity of CCTtrun in the Presence of Various Divalent Cations.  
Each cation has a charge of 2+ and was present at a concentration of 10 mM. Data are the 
average of three determinations and the standard error is indicated by the error bars. 
 
 
 
As yet, no studies exist that show Fe2+, or any iron ion, to be used in the 
cytidylyltransferase reaction.  Additionally, when a measurement of background was 
taken of a Fe2+ reaction with no enzyme, the number of counts accounted for more than 
50% of the total.  This was considered unacceptably high for the radioisotope scintillation 
assay, especially when compared to the other divalent cations, and drastically reduced the 
credibility of this result.  However, L. major has been shown to express LIT1, a divalent 
cation membrane transporter which has a preference for Fe2+ and is transcriptionally up-
regulated by iron deprivation.  LIT1 is also required for intracellular replication of 
amastigotes in macrophages and is required for the development of cutaneous leishmanial 
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lesions in mice (Huynh et al., 2006).  Therefore, it is possible that Fe2+ might cause 
dramatic activation of CCT, which is the rate controlling enzyme responsible for the de 
novo synthesis of PC, to meet the demand for new phospholipid membrane in the rapidly 
multiplying cells.  This hypothesis is further supported by the lack of expression and 
activity of PEMT, the other enzyme responsible for PC synthesis, in Leishmania 
amastigotes (Bibis et al., 2014).  Concerning the other divalent cations, a previous 
member of our lab had shown a similar trend in activity with CCT1, a nuclear isoform 
from D. melanogaster, using the same enzyme assay protocol. Activity of CCT1 was 
actually shown to increase with Mn2+, was 85% with Co2+, 48% with Ni2+, 28% with 
Ca2+, and 25% with Zn2+ at 5 mM concentrations in reference to Mg2+ (Tilley et al., 
2008).   
Ionic radius size may also have a role in the effect of each cation on enzyme 
activity.  The ionic radius of 114 pm, 88 pm, and 87 pm, for Ca2+, Zn2+,  and Cu2+ 
respectively, suggests that these cations may inhibit activity because they are too large to 
effectively incorporate into the cytidylyltransferase active site.  This contrasts with Fe2+, 
Mg2+, Mn2+, Co2+, and Ni2+, which have ionic radii of 75 pm, 86 pm, 81 pm, 79 pm, and 
83 pm (Miessler and Tarr, 2004).  Excluding Fe2+, these smaller cations may be bound at 
the enzyme active site but still induce an unfavorable conformation or be unable to 
efficiently stabilize the phosphate groups present in the substrates, resulting in less 
activity compared to Mg2+. 
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Effect of pH and Temperature on Truncated CCT Activity 
 The pH and temperature at which L. major CCT attained maximal activity was 
source of uncertainty due to the difference in growth conditions between its 
promastigotes and amastigotes forms and how this might impact its intracellular 
environment.  This difference is ultimately due to the difference in host organism; the 
promastigote being present in the primary sand fly vector and the amastigote in the 
secondary mammalian host.  Specifically, promastigotes are cultured at pH 7.5 and 22-
26oC, which imitates the environment of the sand fly midgut (Zilberstein and Shapira, 
1994).  Amastigotes are grown at pH 5.5 and 37oC, which resembles the 
microenvironment of the phagolysosome into which the Leishmania cell is engulfed by 
the mammalian macrophage (Vannier-Santos et al., 2002).  L. major CCT trun activity 
was higher over the more basic range, with its maximum at pH 7.5 (Figure 24).   
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Figure 24. Specific Activity of CCTtrun over a Range of pH.  Data are the average of 
three determinations and the standard error is indicated by the error bars. 
 
 
 
This indicates that if CCT is active in cell-invasive L. major amastigotes, these 
cells must be able to effectively modulate their intracellular pH in order to withstand the 
acidic environment of the macrophage phagolysosome.  Indeed, this harsh 
microenvironment is overcome in L. donovani amastigotes by the action of a plasma 
membrane H+-translocating ATPase which maintains a neutral intracellular cytoplasmic 
pH (Glaser et al., 1992).  CCT trun activity was also highest at 37oC, with only 23% 
maximal activity at 25oC (Figure 25).  
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Figure 25. Specific Activity of CCTtrun at 25 and 37oC.  Data are the average of three 
determinations and the standard error is indicated by the error bars. 
 
 
 
One may discern from these data that, if expressed, CCT would have the highest 
activity in Leishmania amastigotes compared to promastigotes.  Both of these results also 
correspond well to the enzyme assay conditions of pH 7-7.5 and 37oC that are used for 
human, rat, D. melanogaster, C. elegans, and P. falciparum isoforms, which may indicate 
that these conditions are necessary for maximal activity of the conserved catalytic motif 
across species.     
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Two-Step Cloning of the RFP Gene, followed by LmCCT and LmECT Genes, into 
pLEXSY-sat2 
 Using PCR and the specific oligonucleotide primers, a DNA fragment of 
approximately 749 bp for the mCherry gene was amplified from the Hto-RFP plasmid. 
The estimated band size on the agarose gel for each insert included the actual gene sizes 
plus the 5’ and 3’ flanking regions added by the oligonucleotide primers.  The addition of 
2 µL of 50 mM MgSO4 allowed for the greatest amplification of DNA (Figure 26). 
   
 
Figure 26. Agarose Gels of Amplified mCherry PCR Product.  The band observed at 
approximately 749 bp corresponds to the amplified LmCCT gene.  PCR was conducted 
using 1, 2, 4, and 8 µL of 50 mM MgSO4.  1 kb DNA ladder was used as the standard. 
 
 
A 
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Restriction endonuclease digestion with BglII and KpnI of the mCherry PCR 
product yielded a 734 bp DNA fragment insert. Digestion of the 8645 bp pLEXSY-sat2 
plasmid removed a 1080 bp “stuffer region” in the multiple cloning site to give a 7565 bp 
vector (Figure 27).   
 
 
Figure 27. Agarose Gels of Digestion of mCherry PCR Product and pLEXSY-sat2 with 
BglII and KpnI.  The band observed at approximately 734 bp corresponds to the digested 
mCherry insert.  The band observed at approximately 7565 bp corresponds to the 
digested pLEXSY-sat2 plasmid vector.  1 kb DNA ladder was used as the standard. 
 
 
 
This facilitated ligation and formation of the 8299 bp recombinant pLEXSY-sat2-
RFP plasmid. To verify that the recombinant DNA contained the correct insert, plasmid 
DNA was purified in high concentration from nine transformant colonies grown on 
selection plates containing LB and ampicillin.  Each recombinant plasmid preparation 
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was then subjected to another digestion with BglII and KpnI to show removal of the 
desired insert, if present. Digestion of recombinant plasmid DNA purified from several 
colonies showed successful ligation of the correctly sized gene inserts.  Digestion of the 
original plasmid vector, or that which had religated with the stuffer region, may have 
occurred in colonies that failed to produce the desired insert fragment (Figure 28).  
  
 
 
Figure 28. Agarose Gel of pLEXSY-sat2-RFP Redigest with BglII and KpnI.  The band 
observed at approximately 734 bp corresponds to the digested mCherry insert and the 
band observed at approximately 7565 bp corresponds to the digested pLEXSY-sat2 
vector, which indicates successful ligation and formation of the pLEXSY-sat2-RFP 
recombinant plasmid.  1 kb DNA ladder was used as the standard. 
 
 
 
Following the formation of the recombinant pLEXSY-sat2-RFP plasmid vector, 
both CCT and ECT genes were amplified from L. major genomic DNA using a specific 
set of oligonucleotide primers. The estimated band size on the agarose gel for each DNA 
fragment insert was 1796 bp and 1236 bp respectively, and included the actual gene sizes 
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plus the 5’ and 3’ flanking regions added by the oligonucleotide primers.  In the case of 
both reactions, the addition of 2, 4, and 8 µL of 50 mM MgSO4 allowed for the greatest 
amplification of DNA (Figure 29).   
 
 
Figure 29. Agarose Gels of Amplified LmCCT and LmECT PCR Product.  The band 
observed at approximately 1796 bp corresponds to the amplified LmCCT gene.  The band 
observed at approximately 1236 bp corresponds to the amplified LmECT gene.  PCR was 
conducted using 1, 2, 4, and 8 µL of 50 mM MgSO4.  1 kb DNA ladder was used as the 
standard. 
 
 
 
Restriction endonuclease digestion of the LmCCT and LmECT PCR products 
with BglII and XbaI yielded 1778 bp and 1218 bp DNA fragment inserts respectively. 
Digestion of the 8299 bp pLEXSY-sat2-RFP plasmid removed the 14 bp fragment 
between the two restriction sites that had been designed in RFP5 forward primer, yielding 
an 8285 bp vector.  This facilitated ligation and formation of the recombinant pLEXSY-
A 
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sat2-RFP-CCT and pLEXSY-sat2-RFP-ECT plasmids. Digestion of recombinant plasmid 
DNA purified from ten colonies transformed with the pLEXSY-sat2-RFP-CCT plasmid 
and one colony with the pLEXSY-sat2-RFP-ECT plasmid by BglII and XbaI showed 
successful ligation of the correctly sized gene inserts (Figure 30).   
 
 
 
Figure 30. Agarose Gel of pLEXSY-sat2-RFP-CCT and pLEXSY-sat2-RFP-ECT 
Redigest with BglII and XbaI.  The band observed at approximately 1778 bp corresponds 
to the digested LmCCT insert (left) and the band observed at approximately 1218 bp 
corresponds to the digested LmECT insert (right).  The band at approximately 8285 bp 
corresponds to the pLEXSY-sat2-RFP vector. The presence of the insert bands indicates 
successful ligation and formation of both the pLEXSY-sat2-RFP-CCT and pLEXSY-
sat2-RFP-ECT recombinant plasmids.  1 kb DNA ladder was used as the standard. 
 
 
DNA sequencing verified the identity of the mCherry, as well as the L. major 
CCT and ECT gene inserts, and showed no notable discrepancies according to the 
published sequences. 
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Cellular Localization of Leishmania Major CCT and ECT 
 
The LmCCT-mCherry and LmECT-mCherry fusion proteins were both expressed 
in non-pathogenic L. tarentolae to illustrate localization in the native cellular 
environment any other species specific localization mechanisms.  However, it is not 
known if the location of chromosomal integration of the fusion protein genes using the 
5’ssu and 3’ssu homologous recombination sequences in the pLEXSY-sat2 vector caused 
a difference in localization that was regulated by a specific epigenetic effect.  Overlay of 
the images of the mCherry only control showed mixed fluorescence of the green and red 
channels in nucleus but not the kinetoplast, as well as ubiquitous cytoplasmic localization 
throughout the rest of the cell (Figure 31).   
 
 
 
Figure 31. Visualization of the mCherry Control by Confocal Microscopy.  Overlay of L. 
tarentolae cells visualized in the green and red channels.  The larger nucleus and smaller 
kinetoplast were labeled green by excitation of SYBR green using the blue Ar 488 nm 
laser.  The control was labeled red by excitation of the mCherry tag with the green DPSS 
561 nm laser.   
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Overlay of the CCT images showed no mixed fluorescence of the green and red 
channels, suggesting that, unlike those found in humans, rat, or D. melanogaster, the L. 
major CCT isoform did not localize to the nucleus (Wang et al., 1995; Tilley et al., 
2008).  The fusion protein localized to the cytoplasm, but showed an irregular and uneven 
distribution.  Thus, it was determined that L. major CCT is mostly cytoplasmic, which is 
further evidenced by nearly all enzyme activity for CCT being found in the supernatant of 
lysed Leishmania cells.  CCT may also be able to reversibly associate to internal 
membranes within the Leishmania cell such as the endoplasmic reticulum or plasma 
membrane, as this occurs with isoforms of CCT from most other organisms as previously 
described (Kent, 1997).  This may explain why it is not so ubiquitously expressed in the 
cytoplasm as the mCherry only control (Figure 32).  
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Figure 32. Visualization of CCT-mCherry by Confocal Microscopy.  Overlay of L. 
tarentolae cells visualized in the green and red channels.  The larger nucleus and smaller 
kinetoplast were labeled green by excitation of SYBR green using the blue Ar 488 nm 
laser.  The CCT-mCherry fusion protein was labeled red by excitation of the mCherry tag 
with the green DPSS 561 nm laser. 
 
 
 
Overlay of the ECT images showed no mixed fluorescence of the green and red 
channels, suggesting that the L. major ECT isoform did not localize to the nucleus or 
kinetoplast.  ECT was shown to localize ubiquitously throughout the cytoplasm like the 
isoforms from mammals and T. brucei (Vermueulen et al., 1993; Gibellini et al., 2009) 
(Figure 33).   
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Figure 33. Visualization of ECT-mCherry by Confocal Microscopy.  Overlay of L. 
tarentolae cells visualized in the green and red channels.  The larger nucleus and smaller 
kinetoplast were labeled green by excitation of SYBR green using the blue Ar 488 nm 
laser.  The ECT-mCherry fusion protein was labeled red by excitation of the mCherry tag 
with the green DPSS 561 nm laser. 
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Conclusions and Future Work 
Amino acid sequence analysis was used to identify the conserved 
cytidylyltransferase catalytic motif in ECT, as well as a possible amino terminal 
membrane binding domain in CCT.  The genes for CCT and ECT were also 
recombinantly expressed with mCherry red fluorescent protein (RFP) as a fusion protein 
construct in non pathogenic L. tarentolae.  Visualization of the mCherry-tagged fusion 
proteins by confocal microscopy showed that CCT, like other isoforms from other 
organisms, was mostly cytoplasmic and possibly able to reversibly associate with internal 
membranes (Lykidis et al., 1998; Friesen, Park, and Kent, 2001; Tilley et al., 2008).  This 
also revealed that ECT is completely cytoplasmic, as is the case with the isoforms of 
mammals and another parasite, T. brucei (Vermueulen et al., 1993; Gibellini et al., 2009). 
Recombinant DNA encoding CCT from L. major was cloned from genomic DNA 
and the protein was produced by inducible expression in cells containing cold-adapted 
chaperonin proteins.  Purification of the protein was accomplished using metal affinity 
column chromatography and a novel series of washes and incubations with ATP.  
Purified truncated CCT enzyme was then used to assay varying concentrations of CTP 
and [14C] PoC and determined the Vmax to be approximately 374 nmol/mg/min, which 
was very close to that of another intracellular parasite, P. falciparum, but two to three 
orders of magnitude lower compared to those reported for full length isoforms from other 
organisms.  The Km for CTP and PoC was found to be 0.0648 mM and 3.74 mM 
respectively. These seemingly extreme values for Km of both substrates of the enzyme 
from L. major compared to isoforms from other organisms may be explained by a 
difference of substrate concentration and availability within the macrophage host cell 
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(Friesen et al., 1999; Tilley et al., 2008; Helmink and Friesen, 2004; Friesen, Liu, and 
Kent, 2001; Friesen, Park, and Kent, 2001; Yeo et al., 1997).  The Mg2+ ion was used as a 
cofactor in the reaction, but the enzyme was also able to achieve nearly maximal activity 
using Mn2+, Co2+, Ni2+, and possibly Fe2+.  Additionally, the enzyme was most active at 
37oC and pH 7.5. 
The results obtained in this study used established experimental methods and 
were influenced by laboratory capabilities.  As previously stated, this included the use of 
a truncated form of CCT in enzyme assays presumably because the amino terminal 
portion of the protein could not be produced in a bacterial expression system, most likely 
due to its hydrophobic nature.  Therefore, future experiments should primarily be 
concerned with the cloning and production of full length CCT in a suitable, inducible 
expression system, such as the yeasts S. cerevisiae and P. pastoris or mammalian Chinese 
hamster ovary (CHO) cells.  Assay of the full length CCT enzyme may yield more 
accurate kinetic parameters for the enzyme and its substrates, as well as provide a more 
representative influence of divalent metal cations, temperature, and pH on enzyme 
activity.  This would also allow exploration of the effect of anionic lipids on activity, as 
their ability to induce conformational change by mimicking membrane binding plays a 
central role in other CCT isoforms (Friesen et al., 1999; Friesen, Liu, and Kent, 2001; 
Friesen, Park, and Kent, 2001).   
Also, subjecting the amino-terminal region of the full protein to BLAST analysis 
reveals an interesting result. After the initial match to cytidylyltransferases from other 
species of Leishmania, the next highest BLAST score is attributed to several putative 
choline phosphotransferase (CPT) sequences, the third enzyme of the Kennedy pathway. 
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The CPT enzymes to which the amino-terminal region has similarity are from another 
protozoan, Entamoeba histolytica. Similarity was also indicated for a putative 
ethanolamine phosphotransferase (EPT) sequence from the mosquito Aedes aegypti, the 
analogous enzyme of PE synthesis. This presents an intriguing hypothesis of a dual 
function enzyme in Leishmania that catalyzes both the CCT and CPT reactions, directly 
synthesizing phosphatidylcholine from CTP, phosphocholine, and diacylglycerol species.  
Thus, the full length enzyme could be tested for CPT activity by adding diacylglycerol in 
0.1% taurocholate to the standard CCT enzyme assay mixture and looking for PC 
synthesis (Sleight and Kent, 1980).   
Next, the improvement of all biochemical characterization and kinetics studies 
should be paramount.  This would mean the development of a new method to measure 
product formation from enzyme assays instead of radioisotope scintillation counting.  
This method is less accurate and reproducible than others because it measures the amount 
of product formed indirectly; by binding, washing, and releasing from charcoal.  This has 
traditionally been the only method used to measure the amount of CDP-choline produced 
in a CCT assay because of the similarity in structure between CTP and CDP-choline.  
However, very recent development of liquid chromatography- tandem mass spectrometry 
(LC-MS/MS) has shown the ability to separate the substrate CTP and product CDP-
choline using novel gradients of ammonium acetate and acetonitrile (Bapiro et al., 2014; 
Bapiro et al., 2011).  LC-MS/MS would provide a method to directly measure product 
formation, providing more accurate data with less background.  While an improvement 
for all experiments, this would be especially helpful in determining whether the effect of 
Fe2+ on L. major CCT was credible or if this particular cation caused an error in product 
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measurement.  If the former is true, this could lead to a whole new view of the use of iron 
to regulate growth and infectivity in Leishmania.  
Finally, CCT is an attractive potential drug target for leishmaniasis due its 
regulatory activity in the de novo synthesis of PC in the Kennedy pathway.  This is 
strengthened by the hypothesis that the Kennedy pathway may be the predominant route 
for PC synthesis in infective amastigotes, as PEMT activity in these cells is nearly non-
existent and the Leishmania cell would have a wealth of access to choline within the 
mammalian host (Bibis et al., 2014).  The results concerning the biochemical properties 
of the enzyme from L. major are the first step of understanding how CCT functions in 
Leishmania cells.  However, future studies should be primarily focused on expression and 
activity of CCT in the amastigote form; in a time course following its intracellular, 
bloodstream, and tissue-invasive stages.  These experiments would require L. major 
amastigotes cultured from infected mice and the cell lysate supernatant would be used to 
measure enzyme activity.  Measurement of expression would also require the raising of 
specific anti-CCT primary antibodies to use in Western blot immunoassay.  Ultimately, 
results from these experiments would be compared with the data concerning PEMT in L. 
major amastigotes in order to clarify the value of CCT as a potential target in the 
treatment of leishmaniasis.   
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